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1INTRODUCTION*
At the present time most of the salicylates used 
medicinally are synthesised but, as the name indicates, 
the natural source of the drug is the willow tree.
Both the bark and the green willow shoots have been 
valued remedies from ancient times. The Papyrus Ebers 
(approximately 1500 B.C.) included "Rush from the Green 
Willow tree" as one of the ingredients of a cure for 
the Great Debility. A Greek Herbal, compiled during 
the first century A.D* by Dioscorides of Anazarba in 
Cilicia, was a source from which herbalists of all nations 
obtained much information. The English version, trans­
lated by John Goodyer in 1655, revealed an extensive 
knowledge of the properties of the willow and recorded its 
value in the treatment of corns and scurf, as an analgesic 
for "ye griefs of the eares", and as an excellent 
fomentation for gout. More recently, Hasselquist (1872) 
described how the small willow, known as Calaf, was the 
popular remedy for the continual fevers so common in 
Egypt during the Summer Season.
A decoction of willow bark was used as a febrifuge 
throughout Europe. Though Hanzlik (1926) stated that
the French, both before and during the Napoleonic Wars, 
had found that it was a successful substitute for quinine, 
it is surprisingly difficult to trace any writings about 
this use of the ding. One of the first was the letter 
from the Rev. Mr. Edmund Stone that was read before the 
Royal Society in 1763. The extraordinary bitterness of 
the willow bark had led him to believe that it might have 
similar properties to Peruvian bark. Since there was no 
mention of this possibility in books of botany and dispen­
saries, he decided to study this problem. The investigation 
lasted five years and proved that the powdered bark cured 
agues and intermittent disorders and had all the properties 
of quinine, though not always in the same degree. In his 
paper he advanced the argument that - ,Tas this tree delights 
in a moist or wet soil, where agues chiefly abound, the 
general maxim, that many natural maladies carry their own 
cures along with them or that their remedies lie not far 
from their causes, was so very apposite to this particular 
case,....". It is a remarkable coincidence that, when 
Maclaglan in I876 reported the successful use of salicin 
in the treatment of acute rheumatism, he gave almost the 
same reasons for his choice of the drug. "A low-lying, 
damp locality, with a cold rather than a warm climate, 
give the conditions under which rheumatic fever is most
3readily produced. On reflection it seemed to me that 
the plants whose haunts best corresponded to such a 
description were those belonging to the natural order 
Salieinaceae; therefore I determined to search for a 
remedy for acute rheumatism among the salieinaceae, the 
various forms of willow”. As a result of the interest 
aroused by this paper, Ensor (IS76) drew attention to the 
fact that an infusion of willow tops had long been the 
traditional remedy for acute rheumatism amongst the 
Hottentots and the Dutch farmers in the interior of South 
Africa.
It is surprising, that the value of the salicylates 
in the treatment of acute rheumatism escaped notice for 
so long. A possible explanation is that the illness 
was uncommon until large numbers of countryfolk migrated 
to the squalor and poverty of the new industrial towns.
But a more probable reason is that successful treatment 
was impossible in the absence of a correct diagnosis or 
an understanding of the natural course of the disease.
Sydenham (1&4&) described acute rheumatism accurately 
and graphically in the 17th century, but the morbid 
anatomists did not appreciate its relationship to disease 
of the heart until much later (Baillie, 1793 : Dundas, 1&09).
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The acuity of this observation is readily underestimated 
unless one remembers that Corvisart did not publicise 
Auenbruggerfs neglected work on percussion until 1303, 
and that Laennee reported his discovery of the stethoscope 
eleven years later. Once these new methods of examination 
were adopted, physicians were able to diagnose the 
"metastases" of rheumatic fever to the heart at the bedside, 
instead of at autopsy. They soon realised how often 
rheumatism caused chronic ill health in adults but a long 
time elapsed before acute rheumatism and rheumatic carditis 
were recognized as one of the scourges of childhood.
Leonard Findlay (1931) remarked on this fact in his 
introduction to the "Rheumatic Infection in Childhood" and 
pointed out that the true incidence of the disease did not 
become apparent until the clinical examination of children 
was conducted in the same manner as the adult. This more 
careful examination also helped to establish the idea of 
the rheumatic origin of chorea. The first British paper 
on the relationship between chorea and rheumatism had been 
published by Copland in 1321 but it was not until the l360fs 
and 1370*s that chorea, arthritis and carditis were generally 
recognised as being manifestations of the one disease.
The account of the action of salicin upon acute
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rheumatism was published by Maclaglan (1#76) at a most 
fortunate time. By then, the course of the disease 
was understood and its composite nature appreciated.
The value of routine charting of the temperature as an 
aid to diagnosis had been accepted and the jibe that the 
procedure Mcould only amuse physicians in those little 
German hospitals where the number of the staff almost 
equalled that of the patients”, had been discredited.
This method showed quite clearly the striking effect of 
the drug upon the fever. The discovery was welcomed 
because the failure of IB vaunted remedies during the 
preceding fifty years, had produced a sense of futility 
about the possibility of successful treatment (Garrod, 1&90: 
Gull and Sutton, 1&69).
Maclaglan recommended large doses and prescribed 20 - 
30 grains of salicin every 2 hours for adults; and in 
very acute cases, the same quantity every hour until pain 
was relieved and the temperature normal. He expressed 
the opinion that if large and frequently repeated doses 
were accepted as the only form of treatment, valvular 
disease of the heart would, within the next generation, 
become very much less common than it had been.
At the same time as MaclaglanTs empirical discovery, 
Kolbe announced an economical method of preparing salicylic
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acid synthetically (Sollmann, 1943). Buss, in 1375, 
demonstrated its antipyretic action in typhoid, 
tuberculosis, diphtheria and in four patients suffering 
from acute rheumatism* A year later Strieker recognised 
the great therapeutic value of the drug in rheumatic fever. 
Both Maclaglan and Strieker believed that the salicylates 
were specific for the disease. Nevertheless some 
clinicians, who acknowledged the effect of the drug upon 
the joint pains and the temperature doubted whether it 
prevented cardiac damage. In 1331 and 1332 the Medical 
Society of London discussed the question whether "salicylic 
acid robs acute rheumatism of its main terror - the 
liability to heart diseasetf(Broadbent, 1332). Numerous 
papers and statistics were presented but at the end of it 
all the problem remained unsolved (Barlow, 1333; Coupland, 
1332; Gilbart-Smith, 1332; Powell, 1332).
No such doubt troubled D.B. Lees (1903-09) who was 
convinced that the salicylates did more than relieve the 
rheumatic pain. He believed it would soon be generally 
accepted that salicylate was as specific against the 
rheumatic process, as quinine was against malaria or 
mercury against syphilis. He argued that the reason for 
unsuccessful treatment in acute and subacute rheumatism
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or chorea was ineffective dosage. In a mild case, a 
sufficient dose was 150 grains of salicylate a day but 
it was often necessary to increase this to 200 grains 
or 250 grains and in severe cases to 400 grains per day.
He had been able to raise the dose of a boy aged 15 years, 
with a tremendous crop of nodules to a maximum of 600 
grains of salicylate with 1 ,2 0 0 grains of bicarbonate per 
day. There was no danger if certain essential precautions 
were observed. These were that twice as much sodium 
bicarbonate as sodium salicylate must be given, that the 
urine must be alkaline, and that the dose must not be 
increased unless the bowels had moved on the same day.
The inevitable reaction against such heroic treatment 
took place and in 1926 Hanzlik wrote in his monograph on 
the salicylates that the idea of the specificity of the 
drug had been abandoned by students and investigators 
of the subject. Master and Romanoff (1932) in a paper 
on the treatment of rheumatic fever with and without 
salicylates, came to the same conclusion and expressed the 
opinion that these drugs were not specific but "merely 
extremely efficient analgaesics and antipyretics for this 
disease.”
In 1929 Swift expressed concern lest the widespread
use of salicylates had altered the clinical picture of 
the disease so much that few were aware of the natural 
course and duration of the infection. He recommended 
that the classification introduced by Friedlander, some 
fifty years earlier, should be adopted. This recognised 
monocyclic, polycyclic and continuous forms of the 
rheumatic infection. Monocylic rheumatism occurred in a 
third of all the victims and this group recovered without 
relapse in 3 weeks and escaped visceral damage. Most 
patients, however, fell into the polycyclic group and had 
recurring bouts of fever and joint pains. Cardiac damage 
was common. The continuous form occurred less frequently 
but usually affected children, who had no resistance to the 
disease and sustained severe injury to their hearts.
Swift analysed his cases in this way and showed that 
salicylates were efficacious in monocyclic rheumatism, 
masked relapses and induced a false sense of security in 
the polycyclic form; and were of no benefit in the conti­
nuous type of rheumatism.
Opinion in this country has favoured the idea that 
salicylates are specific for the arthritis which is a 
manifestation of the rheumatic infection but that they 
do not have any beneficial effect on any other lesions. 
Rolleston (1923) in his Harveian Oration stated that
9 .
vigorous treatment with salicylates - f,will cut short 
rheumatic fever and so prevent cardiac complications; 
but once these have begun the influence of salicylate 
is disappointing".
The reason for the beneficial action of the sali­
cylates in rheumatism is not known. Stockman (1913) 
pointed out that salicylic acid or ortho-hydroxy-benzoic 
acid was formed by introducing the (OH) group into 
benzoic acid in the ortho position. If the (OH) was 
changed to the meta or para position the anti-rheumatic 
action was abolished and the toxicity greatly reduced.
The theories that have been advanced to explain the 
action of the drug all reflect the ideas about the 
aetiology of rheumatism prevailing at that particular time, 
Maclaglan (1$76) thought that rheumatism and ague belonged 
to the same morbid group and that the specific action of 
the salicylates was comparable to that exerted by quinine 
upon malaria. The miasmatic theory was replaced by the 
infective theory of the disease. It received confirmation 
in 1900, when Poynton and Paine isolated the diplococcus 
rheumaticus. Lees (190$) thought that the specific action 
of the salicylates was due to their bactericidal properties. 
Hanzlik (1926) disapproved of the theory that the
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bactericidal action was due to the liberation of free 
salicylic acid from sodium salicylate when the CO2 
tension in the blood was increased because this was only 
possible at a pH of the blood that was not compatible 
with life.
At the present time rheumatism is often- regarded as 
a manifestation of an abnormal immune response. Great 
significance is attached to the similarity between the 
arthritis of serum sickness and acute rheumatism. Derick, 
Hitchcock and Swift (192&) showed that early, adequate 
and prolonged administration of aspirin to patients who 
had received injections of anti-pneumococcal horse serum, 
prevented the arthritis of serum sickness. They suggested 
that the drug reduced the amount of antibody in circulation 
either by diminishing its production or by altering the 
cell permeability so that none could diffuse into the blood* 
Thus passive sensitisation of the connective tissue of the 
joints was prevented and arthritis avoided.
Coburn and Kapp (1943) reported that sodium salicylate 
modified the precipitation of an antigen by inactivating 
the antibody. The extent of the inhibition depended on the 
concentration of the salicylate.
In a recent survey of the aetiology of rheumatism
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Levinthal (1943) expressed the opinion that the presence 
of antibodies in the circulation was a valuable defense 
mechanism against harmful intra-cellular antigen-antibody 
clashes such as occur in rheumatism. Glazebrook and 
Cookson (1947) accepted this and pointed out that if 
rheumatism resulted because there was insufficient antibody 
to prevent an abnormal immune response, then the aim of 
medical treatment must either be to stimulate antibody 
formation or to mitigate the cellular damage. The work 
of Derick, Hitchcock and Swift (192&) demonstrated that 
the salicylate had no stimulant effect upon antibody 
formation but decreased the amount available. If the 
object was to increase antibody formation it was irrational 
to prescribe the salicylates. As an alternative Glazebrook 
and Cookson (1947) suggested that the drug prevented the 
damaged cell protoplasm from coagulating, its action 
resembling that of heparin which opposed the coagulation 
of the blood and of cell protoplasm and prevented the 
liberation of histamine. They claimed that the 
salicylates owed their beneficial action in rheumatism 
to their anti-coagulant properties.
The inhibitory effect of the salicylates upon the
action of histamine has also been shown in an interesting
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series of investigations on the enzyme hyaluronidase 
(Swyer, 194$). This enzyme is widely distributed and 
can be obtained from bulls’ testes, umbilical cords, 
snake venom and from upwards of 200 strains of haemolytic 
streptococci* It hydrolyses the hyaluronic acid that 
forms the ground substance of connective tissues and 
favours the diffusion of bacteria and toxic substances.
As rheumatism affects predominantly mesenchymal structures 
and usually follows streptococcal infections, it is 
possible that the enzyme is concerned in the production 
of the disease.
Guerra (1946) injected the enzyme plus an indicator 
such as India ink, intradermally into the shaved skin 
of a rabbit’s abdomen, and noted the amount of spread that 
occurred. He found that the oral or intravenous 
administration of sodium salicylate decreased the spreading 
effect of hyaluronidase, and the degree of inhibition 
varied with the dose of salicylate prescribed. He also 
stated that the intradermal injection of hyaluronidase 
and Evans Blue gave ’’unique reactions with enormous 
diffusion of the dye and local oedema” in persons who 
either have or have had rheumatic fever. Salicylates 
reduced the spreading effect in these subjects.
Hechter (1946) found that the spread did not depend
upon the intradermal injection of hyaluronidase and 
suggested that the simple mechanical action of a local 
increase of interstitial pressure explained the 
phenomenon. The initial spread was proportional to 
the thickness of the bleb, and was not influenced by 
the salicylates. Swyer (194$) also failed to confirm 
Guerra’s claim that sodium salicylate inhibited the skin 
diffusing activity. He discovered that Guerra’s prepa­
ration of hyaluronidase contained histamine and that this 
substance by its action on the capillaries enhanced the 
spreading effect. The salicylates had no action upon 
the pure enzyme but markedly inhibited that of any 
preparation that contained histamine. He suggested that 
the salicylates antagonised the histamine.
Interest in the treatment of rheumatism with salicylate 
was re-awakened by the writings of Coburn (1943; 1945).
This work is of importance because it introduced a simple 
method of determining the level of salicylate in the plasma 
and thereby afforded the means of discovering the optimum 
dosage. It also re-stated the old claim that there were 
good reasons for believing that salicylates suppressed the 
sterile inflammatory rheumatic reaction and so inhibited 
further cardiac damage.
In his paper Coburn described the results of an
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investigation into the effect of salicylates on acute 
rheumatism. The work consisted of two parts. The 
preliminary portion was designed to show the greater 
efficacy of large over small doses of sodium salicylate.
For this purpose 43 patients were treated with small 
or Tinadequate* daily doses of 3 - 6 grams whilst 1$ other 
men received either orally or intravenously 10 grams or 
more of the drug per day. He found that sodium salicylate 
in small quantities relieved the symptoms and pyrexia, but 
19 out of this group of 43 patients had polycyclic attacks 
of rheumatism and 16 of them developed cardiac valvular 
disease during the next two years. In contrast to this 
the 1& men treated with massive doses showed a rapid 
clinical recovery and all escaped valvular disease.
The second part of the paper was based on the 
presumption that the erythrocyte sedimentation rate 
expressed the degree of the rheumatic activity and that 
a fall in the rate indicated a suppression of the rheumatic 
reaction. He therefore decided to investigate the 
relationship between the level of salicylate in the blood 
plasma and the erythrocyte sedimentation rate. Two groups 
of 20 patients were selected. The first contained those, 
with proven polycyclic attacks, who had been receiving 
6 grams or less of sodium salicylate per day. In these
cases the levels of salicylate in the plasma varied 
between 0 - 2 5  mgms. per cent. Whilst on this course 
of treatment the erythrocyte sedimentation rates had 
fluctuated and been raised on an average for 49 days and, 
at its conclusion, the rates were not only still elevated 
but showed no tendency to a progressive fall. From this 
it was deduced that doses of less than 6 grams per day 
were inadequate and that though plasma levels of less than 
25 mgms. per 100 ml. sufficed to alleviate symptoms they 
had no effect on the suppression of the rheumatic reaction. 
The sodium salicylate was then increased to a minimum of 
10 grams per day, either orally or intravenously, and as 
a result the erythrocyte sedimentation rate fell promptly 
to normal. Hence these massive doses, that achieved 
levels of salicylate in the plasma between 3 5 - 5 0  mgms. 
per cent., were believed to suppress the cardiac damage.
The second group contained only those patients whose 
first attack was so severe that it was unlikely to be 
monocyclic. They received 10 grams of sodium salicylate, 
either orally or intravenously, from the time of starting 
treatment and attained plasma levels of at least 35 mgms. 
per cent. Within 6 days their erythrocyte sedimentation 
rate began to fall progressively and reached normal 
within 21 days. All these patients escaped valvular heart
16.
disease.
From this Coburn concluded that levels of at least 
35 mgms. per cent caused a rapid fall of the erythrocyte 
sedimentation rate to normal and were necessary to suppress 
the rheumatic reaction. Levels below 20.0 mgms. per cent 
relieved symptoms but masked the rheumatic process.
By combining these two series it will be seen that 
3$ patients, composed of 1$ from the preliminary study 
and the group of 20 in his later study, received large 
doses from the onset of treatment. All these escaped 
valvular damage. The remaining 63 patients were 43 
from the initial experiment and 20 from the second study, 
who had received either inadequate dosage throughout their 
course, or for several weeks before the sodium salicylate 
was increased to the required minimum of 10 grams per day. 
Physical signs of heart disease developed in 21 out of the 
63 in this group.
Coburn estimated that the daily oral dosage necessary 
for the maintenance of an adequate blood level varied 
between 0 .13 and 0 .1 9 grams per kilogram of body weight, 
or approximately li grains per pound of body weight. This 
gave very satisfactory results but intravenous infusions 
produced the desired level more rapidly. He therefore
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recommended the following schedule of treatment :-
TTDay 1 .... 10 grams of sodium salicylate in 1000 cc.
of 0*9% NaCl by I.V. drip in 4 - 6 hours.
Day 2 .... If any rheumatic symptoms persisted or if 
the temperature has not reached normal,
20 grams of sodium salicylate are given 
in 2000 cc. of 0.9% NaCl in 8 hours.
Day 3 .... Repeat day 2 if necessary. If afebrile 
and symptom free 10 grams of sodium 
salicylate is adequate.
Day 4 - 6  Sodium salicylate infusions continued until 
the E.S.R. has made a 20% drop.
Day 7 - 3 0  Oral therapy replaces I.V. therapy. Doses 
of 1 .6  gram of sodium salicylate and 0 .6  
gram of sodium bicarbonate are administered 
every four hours day and night. A total 
of 10 grams of sodium salicylate is given 
daily.
Day 30 ... After two weeks or more in which the E«S*R0 
is within normal limits the patient is 
allowed a trial week in bed without sali­
cylates. If still symptom-free and the 
E.S.R. is still normal the patient is 
allowed up progressively. If frank 
symptoms develop then another 2 weeks 
therapy is indicated.”
In a later paper Coburn (1945) stressed the point that 
salicylate was not the final answer to the problem of the 
treatment of rheumatism. It did not cure but reduced the 
liability to valvular damage of the heart by suppressing 
the inflammatory process. Massive salicylate therapy was 
only a part of the treatment of the disease. He believed 
that proper care should be modelled on the routine adopted
18.
by the U*S* Navy. This consisted of admission to hospital 
at the onset of the rheumatic attack and adequate 
salicylate therapy to cause a rapid and progressive fall 
in the sedimentation rate. Once this had been achieved 
the patient was transferred by air to California where he 
was exposed to increasing amounts of sunlight and allowed 
a carefully controlled resumption of physical activity.
In considering CoburnTs views it must be borne in mind 
that he treated young adults between 17 and 28 years of age* 
It is well known that this age group tends to have monocyclic 
attacks of rheumatic fever and that the fatality rate is low 
and the likelihood of valvular disease is small. An 
accurate, long term comparison of the frequency of cardiac 
damage in adults and children is complicated by the increased 
liability of the latter to recurrent attacks of the disease,
De Liee, Dodge and McEwan (1943) pointed out that this 
difficulty could be obviated by analysing first attacks only. 
In a survey of the literature they showed that the incidence 
was greatly increased in childhood; and this was borne out 
in their own series of cases in which persistent carditis 
was four times more common under the age of 12 years than 
in adults over 25 years of age. Leonard Findlay (1931) 
stated that:- rr the smallest number of deaths and the
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longest duration of the cardiac infection occurred when 
the rheumatism was contracted between 20 and 30 years of 
age*” In an adult the arthritic manifestations are 
prominent and acute and the patient is forced to seek 
early medical attention* This fact was commented on by 
Manchester (1946) who found that the severity of the acute 
manifestations compelled soldiers and sailors to report 
sick before irreparable visceral damage occurred or the 
infection became chronic.
In childhood this is not the case and the transient 
pains are either not noticed or neglected and, all too 
frequently, the child is either brought to the doctor 
only when cardiac damage is far advanced. This aspect 
of the problem is illustrated by the analysis of 1 ,0 0 0  
consecutive cases of juvenile rheumatism quoted by 
Thornton in the chapter on Supervisory Centres in the 
Practitioner Handbook on Child Health.
Acute polyarthritis  ......  1$#5%
Subacute rheumatism 
(includes insidious carditis) •• 52*0%
Chorea .......................... 19.0%
Chorea with concurrent 
subacute rheumatism ............ 1 0 .5%
It is thus seen that in many cases the damage has 
already been done and it is too late to suppress the 
inflammatory reaction. Therefore, it becomes a matter
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of great urgency that the early stages of the rheumatic 
infection in childhood should be recognized and treatment 
begun at once.
Far more attention has been devoted to that part of
Coburn’s paper concerned with the effect of massive doses
of salicylate upon the erythrocyte sedimentation rate than 
to his claim that cardiac valvular disease could be 
prevented or its extent limited. One reason for this is
the long period of time that must elapse before clinical
signs of the lesions develop. It is only now that the 
publication of such studies subsequent to massive salicylate 
therapy, can be expected. Another difficulty has been the 
existence of the different standards of assessing the 
activity or quiescence of the disease or the extent of the 
valvular scarring. This has always been a problem in 
rheumatism. It is a valid criticism of Coburn’s results 
that no criteria of valvular disease or of the signs of 
heart disease are given. When he claims that in the group 
of twenty patients, with "attacks so severe that it seemed 
unlikely that they would be monocyclic", there were no 
residual cardiac valvular disorders at the end of a period 
of two years, one cannot help feeling that widely different 
standards are responsible for many of the divergent results 
and claims.
21.
THE PRESENT INVESTIGATION.
It is obvious that despite all the investigations of 
the past seventy years, the problem of how the salicylates 
relieve the symptoms of acute arthritis remains unsolved.
Many theories have been advanced but none is very convincing, 
Coburn’s confident assertion that massive doses of salicylate 
would suppress the rheumatic reaction provided a fresh 
impetus for further studies. In some of these his claims 
have been criticised but even if only a proportion of cases 
escape valvular damage the use of large doses would be 
justified. Up to the present most investigations have 
been made on acute rheumatism in young adults. It is of 
even greater importance that massive salicylate treatment 
of rheumatism should be studied in children in whom, as 
has already been indicated, the disease is so much more 
dangerous and so often the precursor of the cardiac damage 
seen in adult life.
This study was planned to determine whether children 
would tolerate large doses such as Coburn advocates; the 
frequency of toxic symptoms; and the most suitable system 
of administration. Observations have also been made on 
the effect of "adequate" concentrations of salicylate in 
the plasma upon the erythrocyte sedimentation rate. In
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the course of these investigations the opportunity arose 
to make some studies on rheumatic pneumonia and a short 
account of these is included. Unfortunately it has not 
been possible in the time available to follow up the cases 
for a long enough period and therefore the claim that cardiac 
damage can be limited by massive salicylate therapy has not 
been considered.
The subjects of these studies were thirty two children, 
eighteen boys and fourteen girls, between 4i and 12§ years 
of age who were suffering from acute rheumatism. In 
addition six estimations of the concentration of salicylate 
in the plasma of five other children suffering from acute 
rheumatism #10 were treated with a mixture containing one 
part of sodium salicylate and two parts of sodium bicar­
bonate are included in Chart 6. The period of study was 
from November, 1947 to December, 194$* Facilities for 
this were kindly provided by Professor Stanley Graham in 
his wards in the Royal Hospital for Sick Children, Glasgow, 
and for the biochemical estimations by Dr. H.E. Wilson 
in the Biochemical Laboratory of the same hospital.
Salicylate estimations in the plasma were carried out 
according to the method described by A.F. Coburn (1943): 
the free salicylate in the urine by that of Smith, Gleason, 
Stoll and Ogorzelek (1946): the erythrocyte sedimentation
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rates of the patients by the Westergren method. In 
those experiments on the erythrocyte sedimentation rate 
in which sodium salicylate was added to plasma according 
to the method described by Homburger (1946), the 
sedimentation rate was measured by the Wintrobe method 
and "corrected" from Whitby and Britton1s chart (1942). 
All these estimations were made by the writer.
I
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THE EFFECT OF SINGLE AND REPEATED DOSES OF SODIUM 
BICARBONATE UPON THE CONCENTRATION OF SALICYLATE IN THE BLOOD .
INVESTIGATION.
A knowledge of the concentrations of salicylate in the 
blood plasma after single doses of salicylate is important 
if the massive dosage suggested by Coburn (1943) is to be 
employed* Smith et al. (1946), Lester et al. (1946), 
Huntington et al. (1946), have all shown that the addition 
of sodium bicarbonate has little influence upon the levels 
of salicylate in the blood after single doses of the drugs.
It was decided to check these findings. The levels of 
salicylate in the blood of two healthy subjects were 
investigated after single doses of sodium salicylate, a 
sodium salicylate-sodium bicarbonate mixture, and 
acetylsalicylic acid (Charts 1 & 2). Salicylate is usually 
administered at four hourly intervals and so, the total daily 
dose of the drug was calculated by means of the formula of 
lj grains per pound of body weight that was recommended by 
Coburn, and one sixth of this was given in each experiment.
The levels of salicylate in the plasma were estimated every 
hour during the first four hours and at the end of nine 
hours.
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CHART 1 .
The concentrations of salicylate in the plasma of 
a child after single doses of sodium salicylate, a sodium 
salicylate-sodium bicarbonate mixture, and acetylsalicylic 
acid, lj grains/pound/ day in each instance.
  Sodium salicylate.
  Sodium salicylate-sodium bicarbonate mixture.
  Acetylsalicylic acid (crushed) *
Time in Hours
CHART 2.
The concentrations of salicylate in the plasma of an 
adult after single doses of sodium salicylate, a sodium 
salicylate-sodium bicarbonate mixture, and acetylsalicylic 
acid, lj grains/pound/ day in each instance.
  Sodium salicylate.
  Sodium salicylate-sodium bicarbonate mixture.
  Acetylsalicylic acid (crushed).
  Acetylsalicylic acid (uncrushed).
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The pattern of the absorption curves was similar in 
both subjects. In each, the sodium salicylate and the 
sodium salicylate-sodium bicarbonate mixture produced 
almost identical levels of salicylate in the plasma; they 
reached a peak within two hours and then fell slowly so 
that at the end of six hours a considerable concentration 
persisted in the blood. The acetylsalicylic acid was 
absorbed less rapidly and the maximum was reached after 
four hours when a gradual decline began.
The usual practice was to crush the aspirin tablets 
before their administration but on one occasion (Chart 2) 
they were swallowed whole. A prolonged delay in 
absorption resulted and the peak level of salicylate in the 
blood was not attained for nine hours.
On account of this delay further absorption curves 
were estimated after single doses of crushed acetylsalicylic 
acid tablets had been given to children (Chart 3) • The 
individual doses were calculated in the same manner as 
before. The results confirmed that the peak level was 
usually reached four hours after the dose had been given 
though there was some variation in the rate of absorption. 
The presence of satisfactory levels after six hours was of 
considerable practical importance because this justified
Time
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the prescription of the drug at six hourly intervals.
CHART 3 .
The concentrations of salicylate in the plasma 
of 5 patients dosed with l£ grains of crushed 
acetylsalicylic acid per pound of body weight 
per day.
Though the addition of a single dose of sodium 
bicarbonate has been shown to have little effect upon the 
level of salicylate in the blood, this does not necessarily 
apply during long continued administration. Smull, Wegria 
and Leland (1944) observed that the addition of sodium 
bicarbonate caused a considerable drop in the previously 
constant serum salicylate concentrations. Smith, Gleason 
et al. (1946) adapted CoburnTs method of estimating the
level of salicylate in the plasma so that it was possible 
to determine the amount of free salicylate, salicylurates 
and total salicylates in the urine. They showed that the 
fall in the level of salicylate in the plasma after 
administration of alkali was accompanied by an increased 
excretion of salicylate in the urine, and particularly of 
free salicylate. It was therefore decided to study in 
two children suffering from acute rheumatism the effect 
on the level of salicylate in the plasma of repeated doses 
of alkali, and to make use of the above method for the 
estimation of the free salicylate in the urine. Attention 
was restricted to the excretion of the free salicylate 
fraction in the urine because of the difficulty in 
obtaining the reagent ethylene dichloride. In one of the 
children the effect of increasing the acidity of the blood 
was also investigated.
The first child (M.McD. Chart k) had maintained, on a 
constant dose of salicylate, an average blood salicylate 
level of about 25 mgms. per cent without any wide fluctuations. 
Thirty grains (2 Gms.) of ammonium chloride were added and 
at the end of a week the level of salicylate in the blood had 
almost doubled. The ammonium chloride was then replaced 
by sodium bicarbonate with the result that the pH of the 
urine rose, the amount of free salicylate excreted in the 
urine increased and the level of salicylate in the plasma
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fell. As soon as the sodium bicarbonate was discontinued, 
the pH of the urine was reduced, the amount of free sali­
cylate in the urine diminished and the level of salicylate 
in the plasma rose to its former level.
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CHART 4 .
" THe effect of oral doses of sodium bicarbonate upon
the level of salicylate in the blood; upon the excretion 
of free salicylate in the urine; and upon the urinary pH.
eeee ... Sodium bicarbonate Ammonium chloride
... Acetylsalicylic acid.
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The very close relationship that exists between the 
excretion of free salicylate and the pH of the urine was 
shown even more clearly in the case of W.G. (Chart 5).
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CHART 5.
The effect of oral doses of sodium bicarbonate upon 
the level of salicylate in the blood; upon the 
excretion of free salicylate in the urine; and upon 
the urinary pH.
=  ... Sodium bicarbonate ... Acetylsalicylic acid.
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All the urine passed during six days was collected in 
consecutive periods of six hours. In each specimen the 
quantity of free salicylate was estimated and the pH of the 
urine was measured. It is obvious that when sodium bicar­
bonate is given it has a rapid but transitory effect in 
reducing the level of plasma salicylate, and in increasing 
both the urinary pH and the output of free salicylate. 
Conversely, as soon as the alkali is withdrawn, the earlier 
levels are quickly restored. And the effect can be enhanced 
by giving the child ammonium chloride which, without alter­
ation of the dose of salicylate, produces a rise in plasma 
salicylate and minimal urinary output.
For many years, it has been the custom at the Royal 
Hospital for Sick Children to prescribe sodium salicylate 
together with double the quantity of sodium bicarbonate.
This has proved very satisfactory in that toxic symptoms 
have been infrequent and mild. The effect of doses of 
sodium bicarbonate upon the concentration of salicylate in 
the blood indicated the need to determine if satisfactory 
levels were really being obtained with this mixture. Therefore 
the levels of salicylate in the blood of a group of patients, 
who were being treated for rheumatic fever with a mixture 
containing one part of sodium salicylate to two parts of 
sodium bicarbonate, were estimated. The results were
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disappointing because the concentration of salicylate in 
the plasma rarely exceeded 30 mgms. per 100 ml. and the 
curve often showed a tendency to fall rather than to rise. 
The distribution of the levels is shown in Chart 6. 
Obviously they are widely scattered. The average level 
does not rise much with increase of salicylate intake, 
being 15 mgms with a dosage of 1 gr, per lb. and only 
22 mgms per 100 ml. with dosage of lj gr. per lb. per day.
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CHART 6 .
The distribution of the levels of salicylate in 
the plasma of 17 rheumatic children treated with 
routine doses of a sodium salicylate-sodium 
bicarbonate mixture based upon their body weight.
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There were two possible reasons for these results.
One was that the dose of sodium salicylate was inadequate 
and the other that the amount of sodium bicarbonate in the 
mixture was excessive. The previous experiments had 
suggested that the latter was most probable and so the 
proportion of sodium bicarbonate was reduced either to 
equal the sodium salicylate or to half that amount. The 
alteration in a long established practice led to confusion 
and misunderstanding by the nursing staff and the attempt 
to obtain reliable information in this direction had to be 
abandoned. Instead the sodium salicylate-sodium bicarbonate 
mixtures were replaced by 5 grain tablets of acetylsalicylic 
acid. These were given without bicarbonate.
As soon as acetylsalicylic acid was substituted for the 
sodium salicylate-sodium bicarbonate mixture, without any 
increase in dosage, a marked improvement in the blood 
salicylate levels was noticed. Adequate levels were 
frequently attained. The concentrations in the blood after 
differing amounts of acetylsalicylic acid are shown in 
Chart 7. It is apparent that withdrawal of the alkali 
raised the plasma salicylate from the previous average 
figure of 15 mgms to 30 mgms, with an intake of 1 gr. per 
lb. per day; and from 22 mgms to 40 mgms per 100 ml., 
with an intake of lj gr. per lb. per day.
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CHART 7 .
The distribution of the levels of salicylate in 
the plasma of 25 rheumatic children treated with 
routine doses of acetylsalicylic acid based on 
their body weight.
DISCUSSION.
An important feature of Coburn's "rational treatment" 
of rheumatic fever is the necessity of building up rapidly 
a blood salicylate concentration of at least 35 mgms per 
cent. Various authors have suggested that the presence of
36.
sodium bicarbonate in the traditional sodium salicylate 
mixture accelerated absorption. This affords a more 
acceptable explanation of the clinical custom of 
prescribing sodium bicarbonate in equal or double the 
quantity of sodium salicylate, than the original, but 
now rejected belief, that it protects the gastric mucosa.
In an interesting paper Lolli and Smith (1946) claimed 
that carbon dioxide hastened gastric emptying and 
accelerated absorption. They stated that a moderate 
amount of sodium bicarbonate - "exerts an action 
substantially the same as that of an effervescent mixture" 
because carbon dioxide is liberated by the reaction of the 
hydrochloric acid of the gastric juice with the bicarbonate. 
As a result of the rapid emptying of the stomach, contact 
of the irritant with the sensitive gastric mucosa is reduced 
and the rate of absorption of salicylates from the intestine 
is increased.
This is a neat and attractive theory but it is not 
supported by the present investigation. Charts 1 and 2 show 
that sodium bicarbonate did not increase the rate of 
absorption of sodium salicylate. Indeed the curves that 
represent the concentration of salicylate in the plasma 
after a dose of sodium salicylate and the sodium salicylate- 
sodium bicarbonate mixture are practically identical.
It is evident that even without the help of* sodium 
bicarbonate, the absorption of salicylate is rapid. In 
the case of sodium salicylate the concentration in the 
blood reaches a peak within two hours but acetylsalicylic 
acid is absorbed more slowly and the maximum concentration 
is only reached after four hours. The generally accepted 
conception is, that acetylsalicylic acid is decomposed 
almost entirely in the intestine, and its action is dependent 
on the liberation of salicylate. Smith, Gleason et al. 
(1946) stated - "the slower rise of the plasma salicylate 
curve after aspirin than after sodium salicylate suggests 
that acetylsalicylic acid may be hydrolyzed first before 
absorption". Another feature is that the concentration 
of salicylate in the plasma is slightly lower after a dose 
of acetylsalicylic acid than after sodium salicylate. This 
difference can be explained by the fact that acetylsalicylic 
acid contains only 4/5 ths as much salicyl as an equal 
quantity of sodium salicylate.
These findings correspond closely with those of Smith 
et al. (1946). They gave 2 grams of either sodium 
salicylate or acetylsalicylic acid to aviation students two 
hours after breakfast. In the case of sodium salicylate 
appreciable levels were found in the plasma within half an 
hour; the peak level averaged about 15 mgms per cent and
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occurred after two hours and thereafter fell slowly. 
Acetylsalicylic acid produced a much slower rise and the 
average maximum level of about 10 mgms per cent was reached 
only after four hours and remained constant during the 
succeeding four hours. Lester et al. (1943) found that 
the maximum concentration reached after the ingestion of 
0*65 grams was of the order of 4 mgms per cent and after 
1.30 grams & mgms per cent. Huntington et al. (1946) 
showed that a single dose of $0 grains (3.3 grams) of 
aspirin or sodium salicylate with or without an equal 
quantity of sodium bicarbonate rapidly produced levels of 
19 mgms per cent and in many instances there was considerable 
circulating salicylate at the end of fifteen minutes.
The salicylates are absorbed in varying degrees from 
the skin and mucous membranes, but the most effective site 
is the small intestine. When the drug is swallowed it is 
practically all absorbed in the small intestine and the 
amount excreted in the faeces is negligible. Hanzlik (1926) 
stated that the faeces, as a rule, were free from salicyl 
even after large doses and Coburn (1943) confirmed this 
opinion. The only exception occurs when the absorption 
from the small intestine is hindered by a protective coating. 
Huntington et al. (1946) refer to an "unfortunate experience" 
in which the use of keratin coated capsules of sodium 
salicylate led to an accumulation in the lower gut and the
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sudden production of dangerous blood levels. Yet a delay 
in the absorption of the salicylates may be due to other 
factors. There is an interesting curve in Chart 2 which 
shows that after the administration of a single dose of 
uncrushed aspirin tablets, there was a prolonged delay in 
absorption. As a result of this experience, it is recom­
mended that the tablets should be crushed before a large 
dose is administered.
Many years ago Morris and Graham (1931) drew attention 
to the fact that sodium bicarbonate increased the excretion 
of salicylate in the urine. They attributed this to the 
fact that the sodium bicarbonate prevented an impairment 
of the kidney function. The introduction of CoburnTs 
method of estimating the level of salicylate in the blood 
was soon followed by the accidental observation of Smull, 
Wegria and Leland (1944) that sodium bicarbonate caused 
an abrupt fall in the concentration of salicylate in the 
blood. They investigated the matter more carefully and 
showed clearly that the concentration in the blood fell 
whilst sodium bicarbonate was being administered and rose 
again when it was stopped. Caravati and Cosgrove (1946) 
confirmed this and wrote - "the administration of sodium 
bicarbonate will increase the urinary excretion of salicylate 
promptly, and in general, the higher the pH of the urine,
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the greater the excretion of salicylate.” Smith et al.
(1946) found that the administration of sodium bicarbonate 
along with salicylate produced lower levels than when 
salicylate was given alone. The increased excretion was 
confined to the free salicylate fraction and rose rapidly 
as the urinary pH rose above 7.
Similar results were obtained in this investigation 
and are recorded in Charts 4 and 5* They show that
1) Administration of sodium bicarbonate causes a fall
in the level of salicylate in the plasma.
2) The fall in the level of salicylate in the plasma,
is accompanied by an increased excretion of
free salicylate in the urine.
3) The excretion of free salicylate in the urine
varies according to the pH of the urine.
These observations explain why, though he was unaware 
of the implications, Lees (190&-09^ insisted that twice 
as much sodium bicarbonate as sodium salicylate must be 
given, and that the urine must be rendered alkaline. It 
was only because of the alkalinisation that he was able 
to give with safety to a boy of 16 years the enormous dose 
of 600 grains (40 grams) of sodium salicylate per day.
The blood levels attained with this heroic dosage could
have been reached more cheaply, safely, and quickly with 
the intake of a small fraction of the amount given.
A comparison of Charts 6 and 7 shows that the sodium 
bicarbonate-sodium salicylate mixture produced consistently 
lower levels than acetylsalicylic acid given alone and 
affords another demonstration of the effect of sodium 
bicarbonate upon the concentration of salicylate in the 
blood* The daily dose of lj grains of salicylate per 
pound of body weight, in the sodium bicarbonate-sodium 
salicylate mixture, rarely produced a level above 30 mgms 
per cent. This contrasts with CoburnTs statement that 
levels of 35 - 50 mgms per cent could be attained with this 
amount of salicylate. However, there was the important 
difference that he prescribed one part of sodium bicarbonate 
and two parts of sodium salicylate whilst in this investi­
gation the proportions were reversed. This suggests that 
the unsatisfactory levels in the blood recorded in Chart 6 
are due to the large proportion of sodium bicarbonate in 
the mixture. Indeed Huntington, Ryan et al. (1946) saw no 
reason for giving more than 60 grains of sodium bicarbonate 
daily. It is significant that when a dose of 1 1/4 grains 
of acetylsalicylic acid was given without alkali, this 
often sufficed to maintain a level of 35 - 50 mgmS per cent 
though this form of the drug only contains 4/5ths as much
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salicyl as does sodium salicylate. Glazebrook and Cookson
(1947) have stated that a daily dose of £ grams (120 grains) 
of sodium salicylate will produce a plasma level of 36 mgms 
per cent in the average adult; but that if an equal dose 
of bicarbonate be given with the salicylate, then the daily 
dose of salicylate must be increased to 12 grams (1&0 grains) 
to obtain the same plasma concentrations.
SUMMARY.
1. The concentrations of salicylate in the blood produced
by single doses of sodium salicylate, and a mixture con­
taining equal parts of sodium salicylate and sodium 
bicarbonate were almost identical, Maximuih levels were 
reached in two hours and a slow decline began after four 
hours.
2. ‘ The concentrations of salicylate in the blood produced
by single doses of acetylsalicylic acid were lower than
those obtained by the same dose of sodium salicylate or a 
sodium salicylate mixture. Maximum levels were reached 
after four hours: thereafter the fall was so slow that six
hourly dosage of acetylsalicylic acid was possible. 
Acetylsalicylic acid tablets must be crushed to avoid 
delayed absorption.
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3. The prolonged administration of sodium bicarbonate 
caused a fall in the level of salicylate in the blood. 
Continued intake of ammonium chloride has the opposite 
effect. When alkali was given there was an increased 
excretion of free salicylate in the urine and this varied 
according to the pH of the urine.
4- Doses up to lj grains per pound body weight per day 
of a mixture containing one part of sodium salicylate and 
two parts of sodium bicarbonate failed to produce adequate 
concentrations in the blood.
5. Six-hourly doses of 1 - lj grains per pound of body 
weight per day of acetylsalicylic acid frequently produced 
adequate concentrations in the blood, and the average blood 
levels obtained in a large series of observations was much 
higher than when comparable doses of salicylate-sodium 
bicarbonate mixtures were given. The increase in level 
was from an average of 15 to 22 mgms., with alkali, to 30 
to 40 mgms., without alkali.
6. It would appear, from these findings, that children 
require similar doses of salicylates to adults to enable 
a concentration in the blood to be attained which would 
satisfy Coburn’s stipulations for the successful treatment of 
rheumatism, and that the salicylate should be given without 
alkali.
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THE MAINTENANCE OF MASSIVE SALICYLATE THERAPY AND 
OF A HIGH BLOOD SALICYLATE LEVEL OVER A PROLONGED PERIOD.
There is not much information, obtainable from the 
literature, on the course of events when continued massive 
doses of salicylate are given to children suffering from 
acute rheumatism. Much has been written about the treatment 
of young adults but the dosage suitable for them does not 
necessarily apply to children. There is general agreement 
that when adults are treated with massive doses of salicylate, 
adequate concentrations in the blood are both attained and 
maintained without much trouble or difficulty. But 
amongst those who have had experience with children, there 
is less uniformity of opinion. It has been shown in the 
previous section of this paper that the required levels 
can be attained. It is important to learn what happens 
when they are maintained for some time.
Taran and Jacobs (1945) found that when equal parts 
of sodium bicarbonate and sodium salicylate were prescribed 
for children in oral doses of li grains per pound 
(0*22 Gm per Kilo) of body weight per day, there were no 
difficulties in keeping adequate blood levels. Fashena 
and Walker (1944) found that doses of 0.2 - 0.22 grams of 
sodium salicylate per kilogram were needed during the
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initial 24 hours and that the amount could then be reduced 
to 0.15 - 0.17 gram per kilogram of body weight without 
a fall of the blood level. Acutely ill patients were 
more inclined to show signs of salicylate intoxication 
than convalescent children. Stevens and Kaplan (1945) 
decided that the dosages and blood levels recommended for 
young adults, i.e. lj grains per pound (0.22 Gms. per Kilo.) 
of body weight per day, cannot be prescribed for children 
with safety. Dubow and Solomon (194^) concluded that if 
either sodium salicylate or acetylsalicylic acid was 
prescribed, without sodium bicarbonate, for children 
between 4 - 1 1  years, then 0.15 gram per kilogram of body 
weight maintained a satisfactory therapeutic level for a 
long period; and 0.10 gram per kilogram of body weight 
was insufficient. Maggioni (194&) aimed at a level of 
25 mgms. per 100 ml. or higher and obtained this with a 
total daily dosage of 0.12 - 0.l£ grams per kilogram of 
body weight. Wegria and Smull (1945) treated children 
with enteric coated tablets containing 0.3 gram of sodium 
salicylate and found that by this means vomiting was 
almost entirely eliminated. High levels of salicylate 
in the plasma were obtained only by doubling the estimated 
maintenance dose (lj grains per pound or 0.22 gram per 
kilogram of body weight per day) for the first four doses.
Coburn (1943) believed that it was important to 
achieve a level of at least 35 mgms. per cent quickly if 
the liability to cardiac damage was to be limited.
Because of this the recommendation of Wegria and Smull
(1945) that the first four doses should be doubled was 
adopted. The size of each dose was calculated from the 
daily requirement of 0.22 gram per kilogram of body weight.
Five children suffering from acute rheumatism were 
treated in this way with four-hourly doses of acetylsalicylic
acid. A high concentration of salicylate in the blood was
achieved rapidly, but it involved the use of such enormous 
doses of acetylsalicylic acid that the writer was unable 
to avoid a sense of anxiety. There was no means of 
judging what the response of each new patient would be.
Blood levels varied widely; some bordered on Coburn*s
minimum adequate level of 35 mgms. per cent whilst others 
exceeded his maximum figure of 50 mgms. per cent. It 
was felt that this scheme of treatment was dangerous and 
invited the occurrence of the graver forms of salicylate 
poisoning. Chart & shows the marked variations in the 
early levels and the difficulty of avoiding large
fluctuations.
Therefore, it was no longer considered essential to
Time
The wide variation in the levels of blood 
salicylate produced by a scheme of dosage based on the 
recommendations of Wegria and Smull.
CHART 3.
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achieve a minimum level of salicylate in the blood of 
35 mgms. per 100 ml. within the first 24 - 43 hours, 
but rather to delay this until the third day or even 
longer. The prescription of lj grains of acetylsalicylic 
acid per pound of body weight (0.22 gram per kilogram) 
for two or three days was a sufficient loading dose and 
it was then reduced to 1 1/4 grains or less per pound of 
body weight (0.13 gram per kilogram) per day. By this 
means satisfactory treatment was possible and the blood 
levels were usually stabilised between 40 and 50 mgms 
per 100 ml. (Chart 9^. The concentrations of salicylate 
in the blood during the first ten days of the courses are 
shown. In the case of curve 6 sodium bicarbonate was 
added during the period shown by the broken line and the 
effect of this in lowering the level of salicylate in the 
blood is clearly demonstrated.
The success of any system of dosage depends largely 
upon the degree of supervision that is exercised. For 
this reason an effort was made to keep all the children 
who were being treated with massive doses of salicylate in 
the Royal Hospital for Sick Children itself, but it was 
sometimes necessary to transfer patients to the Country 
Branch before their course was completed. There the 
majority of the patients were convalescent and the nursing
Time
CHART 9 .
The levels of salicylate in the plasma obtained 
by an initial dose of acetylsalieylic acid of l| grains 
(0*22 Gm. per Kilo.) per pound of body weight per day.
  Period when Sodium Bicarbonate was given.
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staff much smaller and for these reasons supervision was 
less meticulous. It was noticed that patients who had 
been stabilised and had maintained adequate levels in the 
parent hospital showed lower blood levels when they were 
transferred to the Country Branch. Chart 10 records the 
results of the last three estimations before discharge to 
the Country Branch and the first three after arrival there, 
wherever possible.
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CHART 10.
The concentrations of salicylate m  the blood of 9 
patients who received the same dose of salicylate 
in Hospital as at the Country Branch.
51
The treatment of juvenile rheumatism with massive 
doses of salicylate soon revealed that the main problem 
was not one of attaining a concentration of 35 - 50 mgms. 
per cent in the blood but the frequent necessity of stopping 
the drug because severe toxic symptoms occurred between 
these levels. This subject will be discussed later.
Hanzlik (1926) stated that the absence of toxicity meant 
the absence of therapeutic efficiency* If this statement 
was modified to read - "absence of toxicity means the 
absence of an adequate therapeutic blood level" it would 
certainly apply to the group of children whom we have 
attempted to treat with large doses of salicylates* These 
signs were sometimes insignificant but, nevertheless, were 
always present. A satisfactory blood level can be attained 
without difficulty but nice judgment is often required to 
strike a balance between the dose needed to maintain the 
blood level and that which will produce toxic symptoms.
The present investigation showed that this ideal was 
fulfilled only when the concentration of salicylate in 
the blood was built up to a minimum of 35 mgms. per cent 
over a period of 2 - 3 days instead of within 24 hours.
The most convenient and reliable scheme was to prescribe 
li grains of acetylsalicylic acid per pound of body 
weight (0.22 gram per kilogram) for the first two or three
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days, and then to reduce it to 1 1/4 grains (0.1& gram per
kilogram) or less® Some of the advantages of a gradual
increase were that a smaller dose of salicylate was 
required, that the levels of salicylate in the blood did 
not fluctuate so wildly'as they did with larger dosage, 
and the symptoms of salicylism were less frequent and mild. 
This modification of Coburn1s recommendation that an 
adequate level of salicylate in the blood should be attained 
speedily, is open to the criticism that the heart may be
seriously damaged during the delay® It is a lesser evil
than the interruption or discontinuance of treatment 
because of toxic symptoms. Graham and Parker (194&) 
adopted a similar scheme with considerable success® They 
agreed with Manchester (1946) that sudden increases in 
the concentration of salicylate in the blood were potent 
causes of salicylism. Such an increase was produced in 
five children treated in accordance with the recommendations 
of Wegria and Smull (1945) but treatment had to be stopped 
in one and severe intoxication developed in three other 
cases. These results strengthened the adverse impression 
that had been formed about this scheme and did nothing to 
dispel the belief that it was dangerous. The extent of 
the risk becomes apparent when it is realised that a 
loading dose of 2\ grains of salicylate per pound of body
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weight (0,36 gram per kilogram) was required during the 
first day i.e. a child who weighed 60 pounds (27 Kilos) 
received 150 grains (10 grams) within 24 hours.
It is possible, though unlikely, that some of these 
difficulties might have been overcome by the intravenous 
administration of salicylates. Despite the fact that 
Coburn had favoured this form of treatment, it was not used 
because of the technical difficulties of the procedure in 
children. A more serious objection was advanced by Taran 
and Jacobs (1945) who reported that the administration of 
the drug by this route had caused the death of a child 
suffering from rheumatic carditis. Even in adults the 
disadvantages outweight any possible benefits. The Committee 
on Salicylate Therapy (1944) and Irving Wright (1945) both 
reported that the only advantage of the intravenous therapy 
was when vomiting or any other symptoms prevented oral 
administration. Griffiths (1947) stated that the method 
was undesirable and unnecessary; and Rosenberg and Hench 
(1946) denied that it was a "superior, more scientific form 
of treatment". Manchester (1946) was an exception and 
recommended the intravenous therapy in severe and intractable 
cases of rheumatism.
Any system of oral dosage will prove unsatisfactory
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unless the patient is given and takes his medicine at the 
prescribed times. This entails close and efficient 
supervision and its absence is a frequent cause of inadequate 
levels of salicylate in the blood. The importance of this 
factor became obvious during the present investigation and is 
clearly demonstrated in Chart 10. Huntington, Ryan et al.
(1946) reported that the salicylates were often taken 
irregularly after a few weeks. They attributed this to the 
fact that the drug was apt to induce a sense of irresponsibility 
even in normal subjects. Butt, Leake et al. (1945) stated 
that the only explanation for unexpectedly low levels was 
that "these subjects in some manner did not take the 
salicylate which was ordered for them". If these lapses 
occur in hospital, there is little chance that massive doses 
of salicylate can be used in a private home.
SUMMARY.
1. Adequate levels of salicylate were obtained within 
24 hours when a loading dose in excess of li grains per 
pound (0.22 gram per kilogram) was prescribed. This 
scheme of dosage may produce dangerously high concentrations 
and wide fluctuations in the blood salicylate. It is 
considered dangerous and is not recommended.
2. Large doses of salicylate were better tolerated when
the concentration in the blood was raised to an adequate 
level over a period of 2 - 3 days. This was obtained by 
a dose of lj grains of acetylsalicylic acid per pound 
(0.22 gram per kilogram) of body weight during the first 
2 - 3  days, and l£ grains per pound (0.1$ gram per kilogram) 
or less for the remainder of the course. On this routine 
a plasma salicylate level of 25 to 47 mgms. per cent could 
be maintained in hospital.
3. Careful supervision was essential to maintain adequate 
concentrations in the blood. For this reason, the 
treatment of a patient at home with massive doses of 
salicylate is unlikely to be successful or safe.
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S ALICILATE INTOXICATION.
When salicylate was first introduced for the treatment 
of rheumatism, it was the custom to prescribe large doses 
of the drug and it is not surprising that references to 
most of the signs and symptoms of salicylate intoxication 
appeared in the early papers. Amongst these was a 
description of those haemorrhagic episodes that are at 
present attracting attention (L.E. Shaw, l&$6-&7)• For 
a long time there was a clinical impression that poisoning
Ax
was more common with the synthetic salicylate than with the 
drug prepared from natural sources. Hanzlik (1926) states 
that this idea was finally discredited by the results 
obtained in different parts of the country by several 
clinicians who were unaware of the character of the 
salicylate that they used.
When smaller dosage became popular these occurrences 
either became less frequent or were no longer reported. 
Salicylate intoxication, however, continued to appear but 
most cases occurred amongst small children who had 
accidentally drunk a liniment that contained oil of 
wintergreen, or in infants whose parents had dosed them 
injudiciously on aspirin for some trivial febrile condition. 
Erganian, Forbes and Case (1947) described thirteen such 
cases amongst children between 3 weeks and kh years of age;
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and Barnett, Powers, Benward and Hartmann (1942) five 
more between & months and 5 10/12 years. These authors 
reminded clinicians that salicylates were poisonous 
when given without proper supervision and that this 
fact was in danger of being forgotten.
The enthusiasm with which Coburnfs methods were 
adopted inevitably led to a great increase of salicylate 
poisoning and many fatalities. These accidents were 
most common in patients who were being treated by the 
intravenous method and were not infrequently attributable 
to the failure of the medical and nursing staff to realise 
the significance of the early signs of toxicity.
VOMITING AND CONSTIPATION.
The common symptoms of salicylate poisoning 
encountered in this investigation were vomiting, hyperpnoea, 
and listlessness. These three were important because 
treatment had to be stopped when any one of them was 
severe. Such a step was not Infrequent and the following 
table gives the reasons for discontinuing treatment:-
5S .
TABLE 1. THE REASONS FOR STOPPING TREATMENT.
Name Reason for stopping treatment
J«G* ... (1) Marked hyperpnoea
Drowsy; vomited once.
(2) Drowsy; looks ill 
Vomited twice.
(3) Hyperpnoea
Looks ill; vomited twice.
A#C. ... Vomited three times
Tinnitus
Onset of congestive failure.
P*M. ... Persistent vomiting
Marked hyperpnoea 
Looked ill
Blood salicylate 55.0 mgms. %
C*B. ... (1) Marked hyperpnoea
(2) Marked hyperpnoea 
Looks ill.
S*M. ... Very listless and drowsy.
R.S. ... Vomited twice.
■J.W. ... Marked hyperpnoea
Looks very ill
Blood salicylate 65.5 mgms. $
E.D. ... Persistent vomiting.
T.M. ... Hyperpnoea
Looks ill
Listless and drowsy 
Incontinent of urine and faeces
J.B. ... Vomited three times.
R.McC. ... Vomited twice.
D.McC. ... Marked hyperpnoea
Pulmonary oedema.
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Vomiting has been reported to be most frequent during 
the first week of treatment and particularly when there had 
been an abrupt rise in the level of salicylate in the blood 
(Keith and Ross, 1945). Graham and Parker (194$) noticed 
that after the first week of treatment higher plasma levels 
were well tolerated and so they made it their practice to 
maintain a level somewhat lower than 35 mgms. per 100 ml. 
for the first 5 - 7  days and to increase the dosage 
thereafter. The unexpected occurrence of sickness later 
in the course of treatment has much greater significance 
and should suggest the possibility of overdosage. A good 
example of this is the case of P.M. aged 7 years, who was 
admitted suffering from rheumatic carditis and treated with 
large doses of acetylsalicylic acid. She received 
100 grains (6.6 grams) during the first 24 hours and then 
60 grains (4 grams) daily. Vomiting occurred on the 
second day but there were no further symptoms until the 
sixth week when she complained of abdominal pain and began 
to vomit continuously. The blood salicylate was found to 
be 55.0 mgms. per cent. Hyperpnoea developed later. 
Treatment was stopped and she made a rapid recovery.
The belief that the vomiting caused by salicylate 
intolerance can be prevented by keeping the bowels freely 
opened has become firmly established in clinical medicine.
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Langmead (1906) came to the conclusion that the "noteworthy
point is that all the patients were constipated before the 
onset of symptoms, so that a greater accumulation than usual
might have taken place« Clearly the indication, then, is
to see that the bowels are kept well opened whilst salicylate
is being given*" Lees (1908-09^ who was in the habit of
giving enormous doses of salicylates - up to 600 grains
(40 grams) per day - supported this view and suggested that
in order to avoid toxic symptoms the dose should never be
increased unless the bowels had moved on that day* Years
later Morris and Graham (1931) wrote that if Langmead1s
advice was remembered it was seldom necessary to interrupt
treatment.
The prevalence of vomiting in the present series of 
cases afforded an opportunity to determine whether LangmeadTs 
conclusions were correct* The results of this study are 
shown in Chart 11 which shows when vomiting occurred and 
the state of the bowels in each child during the first month 
of treatment. It will be seen that no relationship exists 
between vomiting and constipation, and that vomiting is 
most common during the earlier part of the course.
The concentrations of salicylate in the plasma were 
not shown in Chart 11 and so, Table 2 was devised to show 
both the level of salicylate and the condition of the
6 1 .
bowels on the days when the children vomited. Some 
instances of vomiting were excluded from the table because 
the plasma salicylate level had not been estimated on the 
same day.
TABLE 2. RELATIONSHIP BETWEEN VOMITING, PLASMA SALICYLATE,
AND CONSTIPATION.
Name Date Blood level 
in mgms. jo
Whether Number of days 
bowels moved constipated.
D. McF. 6.3.43 33.3 no 1
E • D • 23.1.43 29.3 yes -
24.1.43 29.0 no 1
M. S. 2.3.43 33.7 yes -
A. C. 9.1.43 43.6 yes -
11.1.43 54.7 no 1
12.1.43 40.9 yes -
P. M. 12.2.43 3 2 .0 no 1
19.3.43 55.0 yes . —
R. McC. 13.2.43 34.3 no 2
J. B. 7.11.43 16.4 no 1
A. Li. 7.1.43 14.0 no 2
W. G. 27.2.43 41.9 no 1
29.2.43 44.9 no 1
1.3.43 47.4 yes -
23.4.43 40.0 yes -
26 .4 * 40 33.4 yes -
J. C. 6.3.43 62.2 yes -
25.3.43 17.6 yes -
A. W. 19.7.43 41.9 no 1
D.McC. 22.5.43 42.9 no 1
25.5.43 43.3 no 1
29.5.43 42 .1 no 2
W. S. 10.7.43 45.5 no 1
D.C. 9.7.43 27.2 yes —
12.7.43 20.4 yes —
14.7.43 55.4 no —
J.W, 6.1.43 33.3 yes —
13.1.43 65.5 no 1
14.1.43 65.0 no 2
E.W. 7.5.43 22.1 yes —
27.5.43 47.6 yes —
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Name Date Blood level
in mgms. %
Whether Number of days 
bowels moved constipated.
S. M.
H. McG 
A. Le. 
M. A.
23.5.43
30.3.43
21.3.43
29.3.43 
1.9.43
3 .9 .4 8
9.9.48
20.9.48
48.0
34.4
52.0 
41.6
32.0
34.0 
2 4 .8
40.0
yes
yes
no
no
no
yes
yes
yes
1
3
2
Average level of plasma salicylate when vomiting occurred in 
40 cases - 37*1 mgms. per cent.
Incidence of vomiting
Once more the presence or absence of constipation has 
been shown to have little effect upon the frequency of 
vomiting. In contrast to this, most of the vomiting 
occurred when the concentration of salicylate in the plasma 
exceeded 3 0 mgms. per cent. The average level at which 
vomiting appeared was 37.1 mgms. per cent but this knowledge 
is of little practical value. On the other hand, the fact 
that children may vomit when a level of 30 mgms. per cent
has been reached is important because it draws attention to
(
the possibility that toxic symptoms may be experienced 
before Coburn’s adequate level of 35 - 50 mgms. per cent 
has been attained.
20 times when constipated 
20 times when bowels had moved.
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The influence of the concentration of salicylate in 
the plasma upon the occurrence of vomiting has been 
reported by others, Wegria and Smull (1945) found that 
levels over 50 mgms. per cent produced vomiting in some 
cases; Caravati and Cosgrove (1946) that in 3$ per cent 
of their patients receiving oral salicylates, nausea and 
vomiting developed at a mean plasma salicylate level of 
36,6 mgms. per cent; Graham and Parker (194&) that nausea 
occurred at a mean value of 26.7 mgms. per cent and vomiting 
at a mean value of 23.2 mgms. per cent.
FLUID INTAKE.
In this investigation no attempt was made to ensure 
a large fluid intake. Griffiths (1947) recommended that 
if salicylates were administered absolutely regularly with 
an adequate quantity of water (3,000 ml. per day for adult 
patients) the level in the blood remained at or near the 
optimum® It may be that the lethargy and the toxic 
appearance of the children in the present series was 
largely due to inadequate fluid intake and the adoption of 
Griffith1s recommendation would have prevented them.
Cahill (1946) gave 8 - 10 ounces of water .with each dose 
and was in this way able to prevent nausea.
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Hyperpnoea first appears as a slight increase in the 
depth of breathing and may only become apparent when the 
patient moves in his bed or pulls up his shirt to allow an 
examination of the chest* As the blood level rises, the 
amplitude of the respirations increases and the erroneous 
impression may be produced that the rate has been slowed.
A further rise of the concentration of salicylate in the 
blood causes a more rapid respiratory rate and the breathing 
becomes even deeper, noisy and hissing. By this time the 
patient is in danger of developing the more serious signs 
of salicylate intoxication and it is essential to omit one 
or two doses, or to stop the drug entirely.
The levels at which hyperpnoea occurred are shown in 
Table 3.
TABLE 3. HYPERPNOEA AND BLOOD SALICYLATE LEVEL.
Name Date Blood level in
C*B. 23*2.43 24.8
P.M. 19.3.48 55.0
R.McC. 9.2.48 49.3
11.2.48 37.3
M.McD. 14.3.48 6 4 .8
26.3.48 30.8
15.4.48 43.5
W*G. 2 6.4 .4s 38.4
30.4.48 47.6
5.5.48 43.7
Mara e
a / ,
DaL <2 3ioocl level ii.
W.S. 19.6.43 34.3
28.6.43 39.8
D.McC. 21.5.48 42.9
27.5.43 54.0
30.5.48 42.1
E.W. 10.5.48 33.7
20.5.43 36.4
23.5.48 50.3
J.W. 14.1.48 6 5.O
S.M. 20.5.48 28.0
23.5.48 48.0
25.5.48 36.0
M.H. 17.8.48 41.0
20.8.48 55.2
23.8 .4 8 40.8
27.8 .48 40.8
H.McG. 31.8.48 34*4
7.9.48 23.0
10.9.48 32.8
A.Le. 21.8.48 52.0
27.8 .4 8 40.3
T.M. 17.8.48 32.8
19.8.48 48.8
23.8.48 34.0
30.8.48 51.2
D.C. 9.7.48 36.2
J.C. 6.3.48 62.2
M.McD. 6.10.48 35.6
8.10.48 38.0
18.10.48 40.0
21.10.48 40.0
M.A. 2 9.8 .48 41.6
31.8.48 32.0
3.9.48 34.0
6.9 .48 47.2
9.9.48 24.8
- 13.9.48 31.2
20.9.48 40.0
Average level ... 41*3 mgms. per cent.
Despite many investigations, there is still a
considerable difference of opinion about the cause of the 
hyperpnoea of salicylate poisoning* Troll and Menten 
(1945) divided the possible explanations into four groups.
The first of these is that the condition may be due 
to an acidosis. This is no new idea for Langmead (1906) 
thought that the air-hunger was similar to that which 
occurred in diabetic coma and that it was one of the 
symptoms of acid poisoning. Morris and Graham (1931) 
found hyperpnoea of a greater or lesser degree in all of 
their cases and regarded it as a typical acyanotic dyspnoea 
due to an acidosis of an acid-poisoning type. They 
suggested that an impairment of renal function was an 
important factor in its production. Johnson (1930), as a 
result of administering salicylates in doses equivalent 
to 0.2 Gnu per Kilo, to rabbits and cats, concluded that 
there was a fixed-acid acidosis compensated for by loss of 
carbon dioxide. He dismissed the possibility that the 
salicylates might cause an alkalosis by stimulating 
respiration because the apnoea that is found after forced 
ventilation did not occur.
The second suggestion is that there is a stimulation 
of the respiratory centre by the salicylates. This was 
the view of Marten - Odin (1932) who believed that the 
deep breathing was brought about through irritation of the
respiratory centre. Barnett et al. (1942), and Hartmann 
(1945) were of the opinion that there was a primary 
hyperventilation due to a specific central stimulation 
which led to a carbon dioxide type of alkalosis. This 
was then replaced by a ketosis due either to depletion of 
the glycogen reserves or to dehydration, and both of these 
factors would be increased in the presence of vomiting.
The combined effect of central stimulation and acidosis 
accounted for the characteristic intense hyperpnoea.
Somewhat similar opinions are held by Fashena and Walker
(1944) who stated "it would appear that this distortion of 
the acid-base equilibrium which occurs in acute salicyl 
poisoning is a complex phenomenon resulting from many 
factors viz., primary stimulation of the respiratory centre, 
fixed acid acidosis, ketosis, and possibly other changes." 
The importance of the ketosis is doubtful for Myers and 
Ferguson (1929) found no increase in ketones in men or 
rabbits receiving large doses of salicylates. Rapoport and 
Guest (1945), as a result of experiments on monkeys and dogs 
and then in man, found that the salicylates caused a primary 
hyperventilation and a significant elevation of the serum 
pH in most instances. An hypnotic drug such as pento­
barbital sodium suppressed the hyperventilation, though it 
increased the toxicity, and they interpreted this as an 
indication of a direct action of the salicylates on the
respiratory centre. Ryder, Shaver and Ferris (1945) 
reported a fatal case of salicylate poisoning in which a 
respiratory alkalosis developed and tetany was observed. 
Graham and Parker (194$) injected salicylates intravenously 
into rabbits and adult male patients suffering from chronic 
rheumatoid arthritis and concluded that the drug had a 
rtdirect stimulant effect on the respiratory mechanism which 
is independent of alteration of the blood acid-base balance.TT 
They remarked that the general assumption, that the 
salicylates have a direct stimulant effect on the respiratory 
centre, ignored the observation of Danewski that vagotomy 
inhibits the hyperpnoea in experimental animals. This fact 
was confirmed by experiments ,on both cats and rabbits. From
their work it seems that the site of stimulation is a 
peripheral one acting through the vagal nerve fibres.
The third concept is that the hyperpnoea is due to an
increased metabolism* This is supported by Dodd, Minot 
and Arena (1937) who, as a result of experiments on dogs, 
wrote - "the sensation of heat and the increase in gaseous 
exchange induced by salicylates appear to us to be of much 
greater importance in producing an increase of the 
respiratory rate and depth than any direct central action 
of the drug." These authors made the interesting 
observation that by artificially cooling animals that were 
being given salicylate there was no significant change in
the respiratory rate while the uncooled animals had extreme 
dyspnoea.
The fourth suggestion is that the salicylates damage 
the endothelium of the capillaries and that an early increase 
in the permeability of the vessels occurs. Ashworth and 
McKemie (1944) examined two fatal cases of salicylate 
intoxication and concluded that the - "severe generalized 
hyperemia in our two cases suggests the possibility of some 
capillary damage by the salicylatesTt. Troll and Menten
(1945) also found that in the course of damage to the tissues 
an early increased permeability of the vessels occurred.
This increased the rigidity of the lungs and produced the 
"reflex dyspnoea” described by Christie (193$) •
These differences of opinion indicate how difficult it 
is to explain the underlying mechanism of the hyperpnoea.
Of the four possible causes, the theory that attributes the 
dyspnoea to increased metabolism is an unlikely one, and it 
seems more reasonable that the opposite is true and the 
dyspnoea stimulates metabolism. The demonstration that an 
alkalosis exists in salicylate poisoning undermines the 
belief that an acidosis is the causative factor of the 
dyspnoea* On the whole present opinion favours the view 
that the salicylates have a direct stimulant effect upon the
respiratory centre or, as Graham and Parker (194$) prefer, 
upon the respiratory mechanism.
DROWSINESS.
The appearance of listlessness and drowsiness may 
easily be missed during the first few days after admission 
to hospital when the child is a stranger and little is 
known about him. But in many cases there is an obvious 
pallor and the patient looks ill and has dry lips and a 
parched tongue. These symptoms afford a warning that 
careful supervision is required, and if they persist the 
dose of salicylate must be reduced or treatment stopped.
A rapid and striking improvement occurs when this is done 
and within 24 hours a dull, lethargic child becomes quite 
animated.
HAEMORRHAGE.
Four other symptoms of salicylate intoxication are 
often mentioned in the literature. These are tinnitus, 
delirium, haemorrhages and an acneiform eruption. There 
were epistaxes in five patients and four of them were 
being treated with salicylates at that time. Because 
the prothrombin time of the blood of these children was 
not estimated, no opinion could be formed whether the 
haemorrhages were a manifestation of the rheumatic infection 
or the effect of the salicylate.
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The occurrence of an acneiform rash has been mentioned 
by several writers. It was one of the three toxic 
reactions recorded by Coombs, Warren and Higley (1945) who 
were impressed with the frequency of toxic effects when the 
plasma salicylate was maintained at levels over 30 mgms. 
per cent* Graham and Parker (194$) saw two instances of 
rash, in the third week of salicylate therapy, when the 
plasma levels had fallen from an initial high level*
Keith and Ross (1945) recorded the appearance of a rash in 
one patient of their series.
During the present investigation a rash was found on 
only one child and it was not at first recognized as being 
a toxic manifestation of salicylate therapy. The following 
is a summary of the story:- M.McD., aged 11 years and 
weighing 29*6 kilograms, was admitted to hospital on 
13*3*4$ as a case of subacute rheumatism and at once 
received massive doses of acetylsalicylic acid - 150 grains 
(10 grams) within the first 24 hours and 5 0 - 6 0  grains 
(3*3 to 4 grams) daily for the rest of her stay in hospital. 
On the day after admission to hospital (14*3*4$) she 
attained a plasma salicylate level of 64*$ mgms. per cent 
and this fell to 3$.3 mgms. per cent by 19*3*4$. She was 
then found to have a crop of purulent vesicles over her
right buttock. One of the lesions was opened and from the 
pus a few colonies of staphylococcus aureus were grown.
The pustules persisted and on 23.3*4$ this note was made - 
Mthe diagnosis of this skin condition causes some difficulty 
a staphylococcal skin infection - not echthyma or BockhartTs 
impetigo.TT She was treated with 50,000 units of penicillin 
four times a day. The rash healed by 31*3*4$ though an 
occasional pustule was noticed subsequently. She was 
dismissed home on 22.4*4$* Apart from the initial high 
blood levels the serial estimations in this child averaged 
about 25 mgms. per 100 ml. It is now believed that the 
eruption was either the direct result of salicylate toxicity 
or a sequel to the sweating induced by the drug. The case 
resembled those described by Graham and Parker (194$) in 
that the rash appeared when the level of salicylate in the 
plasma had fallen from the initial high concentration.
DEAFNESS AMD TINNITUS.
Adults often complain of deafness and tinnitus during 
treatment with salicylates. This is so common that some 
clinicians believe that patients are receiving inadequate 
treatment if this symptom is absent. But is is of little 
value in young children who seldom complain of either 
deafness or a buzzing in the ears. They do experience 
these symptoms but the younger ones do not have the
vocabulary or are unable to explain their odd sensation. 
However, if the child is questioned carefully, he will 
often reveal that he has tinnitus and may even be persuaded 
to reproduce the hissing sound that is troubling him. In 
the case of older children the deafness can be detected more 
easily but it is not often a prominent feature•
DISCUSSION.
During the first part of this investigation the signs 
and symptoms of salicylism were not always appreciated and 
information about the concentration of salicylate in the 
plasma was a valuable safeguard against overdosage. But 
with more experience the various stages of salicylate 
intoxication were recognized clinically and their severity 
was assessed with considerable accuracy. This improvement 
in detection was accompanied by an apparent increase in the 
incidence of salicylism because many cases that had been 
overlooked before were now noted. The condition was seldom 
observed when the concentration of salicylate in the plasma 
remained low but occurred with increasing frequency as the 
level of the drug rose above 30 mgms. per cent. Indeed 
signs of salicylate intoxication became common when the 
concentration of salicylate in the plasma lay between 
35 - 50 mgms. per cent. This provided unexpected support 
for the old clinical belief that the drug should be
prescribed in doses sufficient to produce symptoms of 
poisoning. It also renewed interest in the possibility 
that the common signs and symptoms of salicylism might 
provide a useful guide to the lvel of salicylate in the 
plasma.
The value of an estimation of the concentration of 
salicylate in the plasma is not questioned but reliance 
on the blood level implies certain limitations and 
disadvantages. The most important is that massive 
salicylate therapy must be restricted to hospital practice 
because the determination of blood levels requires 
laboratory facilities. In addition, the repeated with­
drawal of blood may become an ordeal to some children.
It was found in the present investigation that some 
subjects came to dread the procedure of blood sampling.
For these reasons any alternative means of gauging the 
level of salicylate in the plasma was welcomed, even if 
it was but an approximation.
Amongst the older clinicians buzzing ears or deafness 
was commonly regarded as a reliable indication that an 
effective dose of salicylate had been prescribed. These 
symptoms proved of little value in this investigation 
because the children were seldom troubled by them.
Vomiting and listlessness occurred more often but their 
unpleasantness was a barrier to their use during a 
prolonged course of treatment. On the other hand, 
hyperpnoea possessed many advantages as an indicator.
The breathing could be observed at any time; did not 
depend upon the co-operation of the child; and caused no 
distress. As the investigation progressed the presence 
of hyperpnoea was accepted as an assurance that the 
salicylate in the blood either had attained or was approaching 
an adequate concentration. The most satisfactory results 
were obtained when mild rather than obvious hyperpnoea was 
present because other toxic symptoms were not common at 
this stage. Success depended upon an ability to detect the 
increase in the depth of respiration that preceded acceler­
ation of the rate of breathing.
SUMMARY.
1. The incidence of salicylate intoxication has increased 
since the resumption of massive salicylate therapy.
2. Vomiting, hyperpnoea and listlessness were common 
and the usual reasons for stopping treatment.
3. Vomiting was not caused by constipation but tended 
to occur when the concentration of salicylate in the blood
exceeded 30 mgms. per cent. The average concentration of 
salicylate in the blood when vomiting began was 37.1 mgms. 
per cent.
4* Hyperpnoea was noticed when the average concentration
of salicylate in the blood was 41*3 mgms. per cent. The 
cause of the hyperpnoea of salicylate intoxication is not 
known but the various theories have been described. The 
early stage of hyperpnoea, i.e. increase in depth of 
respiration without increase of rate, was the best clinical 
indication that the concentration of salicylate in the 
plasma was adequate.
5. An acneiform rash developed in one child and has 
been described.
6. Children are often unable to describe tinnitus or 
deafness and so these were not common complaints.
RHEUMAT1C PNEUMONIA.
In this investigation three cases developed clinical 
signs of pulmonary involvement, and a fourth showed X-ray 
evidence of consolidation. The possibility at once 
suggests itself that these cases were examples of rheumatic 
pneumonia. This condition has been the subject of several 
recent papers. Seldin, Kaplan and Bunting (194$) stated 
that two fairly distinct clinical syndromes have been 
evolved. The first of these occurs in the more severe 
types of the rheumatic infection and was described by 
Rabinowitz (1926) as - rrthose cases developed without upper 
respiratory symptoms or chill; they presented only slight 
cough, little toxaemia, irregular elevation of temperature, 
areas of marked dulness, and loud bronchial breathing with 
but few rales. They were of fleeting character, and, as 
a rule did not influence the prognosis.TT The second type 
is more severe and may end fatally. Gouley (1937) 
described these cases as - rTa small group of patients in 
whom the pulmonary invasion is extremely rapid and 
widespread, accompanied by quickly developing dyspnoea 
and cyanosis.» Griffiths, Phillips and Asher (1946) sub­
divided this group into primary and secondary forms and 
classified the rheumatic pneumonias into 3 types :-
1. Primary acute pneumonitis in which the pneumonia is
the initial symptom of the rheumatic episode.
2. Secondary acute pneumonitis which developed during
one of the phases of polycylic rheumatism.
3. Subclinical pneumonitis which is often found
accidentally and should be suspected "when a 
rheumatic fever patient is more ill than 
clinical findings would indicate*"
The case histories of the four children who developed 
signs of pulmonary involvement will be described in detail.
CASE 1 .
D.McC., aged 9 years, was admitted to hospital on 
17*5«4&. From the age of 5 years he had been subject to 
sore throats every autumn. In October 1947, he developed 
a sore throat, swollen cervical glands and became very 
pale. His condition was attributed to poison from his 
teeth and so eight teeth were extracted. From then 
onwards he was never well. On 23.5*4$ be became paler, 
listless and breathless on exertion, and had vague pains 
in his legs. He was treated at home as a case of 
rheumatism for the next three weeks and then, because of 
a severe epistaxis, was admitted to hospital. On 
examination his apex beat was found in the 5th space one
inch outside the nipple line, and a loud systolic apical 
murmur was present. The lungs were clear. He was 
treated with acetylsalicylic acid 105 grains (i.e. lj 
grains per pound of body weight per day) from IS*5.48 to 
22.5-4#; 90 grains per day from 23-5*4# to 28.5*4#; and
75 grains per day from 29*5*4# to 30.5-4# when treatment 
was stopped. Blood levels between 42 - 54 mgms. per 100 ml. 
were maintained. During most of this period he was inclined 
to be drowsy, listless, and his respirations were increased 
in amplitude though not in rate. In the evening of 30.5-4# 
he became very restless, his breathing rapid and deep, and 
he appeared ill. The acetylsalicylic acid was discontinued 
and sodium bicarbonate grains 30 was given every four hours. 
Next morning (31*5*4#) he still looked ill, was very 
dyspnoeic and had a cough. His face was slightly puffy.
The percussion note was resonant; the respiratory murmur 
was vesicular and there was abundant rale at both bases.
On 1.6.4# the following note was entered in his case record - 
"boy looks pale and ill with cough and increase in 
respiration rate but not in temperature and pulse rate.
He has, however, had a low grade fever for some days. Heart 
now not as large as on admission: apex beat in the 5th
space one third of an inch outside the nipple line. No 
dulness but abundant fine rale all over left lung back and
$2.
front and at right base." X-ray of his chest showed - 
" + mediastinal and heart shadows: suggests infiltration
and - H -  oedema. No fluid visible in pleural sacs."
The boy made rapid improvement and though scanty rale was 
present for a few days, this cleared by 6.6.4&*
CASE 2 .
J*W. aged 6 years, had scarlatina in September 1947 
and was dismissed home well from the Fever Hospital about 
the beginning of October. Three weeks later she developed 
fever, and a slight rash appeared on her arms and legs.
In early November she had epistaxes and a heart murmur was 
discovered. Since then, in spite of rest in bed, she had 
had some joint pains and several epistaxes. Because of 
these she was admitted to hospital. On admission she was 
found to have an enlarged heart. The apex beat was 
palpable in the sixth space half an inch outside the nipple 
line and there was a forceful thrust* and a thrill which 
could not be timed because of the rapid heart rate (circa 
140 per minute). The rhythm was regular. Systolic and 
diastolic murmurs were heard at the apex. The lungs were 
clear. She was given a mixture containing sodium salicylate 
grains 10 and sodium bicarbonate grains 20 every four hours 
from 4.1.4$. On 6.1.4$ her blood salicylate was 3&.3 mgms. 
per 100 ml. The child vomited at least once each day and
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because of this acetylsalicylic acid grains 10 was 
substituted for the sodium salicylate mixture on 10.6.4#. 
There was no vomiting for the next two days.
On 13.1.4# she refused her food and vomited once.
The blood salicylate concentration was 65*5 mgms. per 100 ml. 
Next day (14.1.4#) the child, though afebrile, was pale and 
looked ill. Her pulse and respirations were rapid, she 
had a short dry cough and the alae nasae were dilating. An 
examination of the lungs showed that the percussion note 
was slightly impaired at the right apex in front and in the 
right axilla where the respiratory murmur was distinctly 
tubular and many fine crepitations were heard. There was 
no oedema. Later in the day the child’s breathing became 
markedly acidotic and, as the level of salicylate in the 
blood was 65.0 mgms. per cent, the drug was stopped. By 
the evening she was restless, pale and very ill. An 
intensely tubular respiratory murmur could be heard at the 
right base and right axilla. Soon after this an intravenous 
drip was set up.
During the night the general condition improved and on 
15.1.4# she was breathing more easily and slowly. She had 
a frequent cough and occasional small epistaxes. The 
condition of the lungs was unchanged. An X-ray film of the
chest showed extensive areas of consolidation in both lungs, 
enlarged heart shadows and a large pulmonary conus. On 
17.1*4# she was noticed to have a puffy face and some lumbar 
oedema. She had a cough and there was much rale at the 
right axilla and right base. The oedema became more 
widespread and on 20.1.4# she was given Digoxin. There 
after she improved steadily and on 17*2.4# the following 
note was made - ’’remarkably well having regard to previous 
condition ... I think much of the unexpected improvement 
can be attributed to Digoxin.”
CASE 3 .
J.C., aged 7 3/12 years had been treated in the 
hospital for pericarditis in April 1946. About 1#.2.4# 
he complained of headache, sore throat and anorexia, 
followed a few days later by pains in his knees and down 
his shins. He was admitted to hospital on 27.2.4# and 
found to have an enlarged heart with the apex beat 
palpable in the 6th space one inch outside the nipple line. 
Systolic and diastolic murmurs were heard at the base and 
apex. During the next six weeks he received two courses 
of salicylate therapy both of which were stopped because 
he developed signs of salicylism. On 19.4*4# he became 
fevered, had pains in his legs, and his erythrocyte 
sedimentation rate which had previously been 12 mms. rose
to 50 mms. in one hour. Treatment with sodium salicylate 
grains 10 every four hours was begun on 20.4*4$ but though 
the temperature settled after three days there was an 
increase in the pulse rate. On the 24th he vomited, his 
respirations became more rapid and he began to cough. 
Widespread rhonchi were heard*over the right lung. In 
the evening of 2 5*4 *4$ he vomited twice, his respirations 
became rapid and deep and he did not look well. The 
salicylates were stopped. Unfortunately the concentration 
of salicylate in the plasma was not measured during this 
course of salicylate medication but some hours after 
treatment was discontinued the level was 17*6 mgms. per 
cent. There was little improvement next day and on 27*4*4$ 
the following note was made in his case record 
"temperature remains elevated and the child is very ill. 
Respirations are pneumonic in type - dilatation of the 
alae nasae, expiratory grunt and inversion of the respiratory 
rhythm. Frequent cough. Lungs - percussion note decreased 
in the right axilla and respiratory murmur harsh vesicular. 
Numerous rhonchi and rales scattered throughout both lungs." 
For the next five days he was treated with sulphamezathine
and his condition gradually improved.
CASE 4 *
WoS., aged 4 years and 10 months, was admitted on
24.5.4$ suffering from rheumatic carditis. He was treated
with calcium aspirin 40 grains daily. Un 2*6.48 he 
suddenly developed fever, sweated profusely and shivered.
He did not feel ill. No cause was found for the condition. 
On 3.6.4$ his chest was X-rayed and a widespread conso­
lidation of the right lung was found. The blood salicylate 
level on 4*6.4$ was 35 mgms. per 100 ml. During the next 
week his fever subsided though he did complain of two 
bouts of sweating. On 19*6.4$ he seemed so well that the 
course of calcium aspirin was stopped.
These four cases are regarded as examples of rheumatic 
pneumonia. Cases 1, 2 and 3 fall into the fseveref type 
described by Seldin, Kaplan et al. (194$), or the secondary 
acute pneumonitis of Griffiths (1946). The X-ray picture 
of D.McC. (case 1) shows an appearance very similar to the 
plates reproduced in the paper by Seldin et al. (194$)•
Case 2 illustrates the view of Griffiths et al. (1946} 
that - "where there is a primary right sided heart failure 
in rheumatic fever, pneumonitis is one of initiating 
causes." Case 4 is an example of subclioicaX pneumonitis.
Rheumatic pneumonia has been attributed to a specific 
rheumatic manifestation, to congestive failure, to inter- 
current infection and to a combination of rheumatic 
activity and cardiac failure. All these theories have
been disputed. It is felt, though no proof is offered, that 
these complications which arose during the course of 
salicylate medication in the present series, were not 
accidental infections but a direct result of a high level 
of salicylate in the blood. Cameron (194$) in his Sidney 
Ringer Memorial Lecture on pulmonary oedema referred to 
the wide variety of drugs -one of these was methyl 
salicylate - that can cause pulmonary oedema after 
absorption into the blood stream. He had also been 
impressed by the frequency of severe dyspnoea before the 
oedema reached its clinical crisis and was inclined to the 
view that such respiratory embarrassment played an important 
part in the causation of the oedema.
Confirmation of the importance of dyspnoea and the 
exudation of plasma from the damaged capillaries is contained 
in HadfieldTs (193$) paper on the "Rheumatic Lung". He 
described how the consolidated lung had a red, rubber-like 
consistency, and the small amount of fluid that could be 
expressed from it. The aerated parts, however, invariably 
showed acute oedema and contained a large excess of watery, 
blood stained fluid.
In many of the accounts of rheumatic pneumonia it is 
difficult to decide whether or not salicylates were given,
and when they were, few details about dosage are recorded. 
It is suggestive that two of the severe cases in this 
investigation had adequate levels of salicylate in the 
plasma and the third, though the concentration of 
salicylate in the plasma during the course of treatment 
was not estimated, had been unable to tolerate salicylate 
on two earlier occasions. Murphy (1945) mentioned that 
he encountered a fatal case of rheumatic pneumonitis with 
a level above 30 mgms. per cent. The paper by Stevens 
and Kaplan (1945) on salicylate intoxication affords some 
confirmation of the suggestion that there is a relationship 
between high blood salicylate levels and pulmonary lesions. 
They described four cases, one of which proved fatal.
This patient attained an extremely high blood salicylate 
level and developed pulmonary oedema with signs of 
circulatory failure. Microscopic examination of the lungs 
showed - "early acute bronchitis, severe pulmonary oedema, 
extreme congestion and a few small perivascular haemorrhages 
within the interlobular septa." X-ray plates of these 
patients showed that one had appearances "consistent with 
bilateral bronchopneumonia", and the other had "a focus 
of irregular consolidation that could not be confirmed by 
clinical examination" in the upper lobe of the right lung.
THJi EFFECT Or' s A L IuYLa TE UiM THe  ERYTHROCYTE
SEDIMENTATION RATE.
It is widely accepted that, in the absence of gross 
anaemia, the presence of a raised erythrocyte sedimentation 
rate in a case of rheumatism indicates that the disease is 
still active. But if this estimation is used as a means 
of assessing progress or gauging the effect of a drug it 
is well to remember the advice given by Massell (193$) at 
a Round Table Conference of the American Academy of 
Pediatrics:- "many investigators who have written about 
the erythrocyte sedimentation rate in these conditions have 
claimed a remarkable infallibility. They have implied or 
stated directly that an elevated erythrocyte sedimentation 
rate proves the presence of active infection and that a 
normal E.S.R. proves the absence of active infection. If 
the word 1 suggestsT were substituted for 1 proves1 this 
statement would be more nearly correct."
Coburn (1943) claimed that massive doses of salicylate 
hastened the fall of the erythrocyte sedimentation rate to 
normal in cases of monocyclic rheumatism, and cited this in 
support of his view that the rheumatic activity was 
suppressed by the drug. If he is correct, cases with a 
blood salicylate level above 35 mgms. per cent should require
90.
less time for the erythrocyte sedimentation rate to reach 
normal than those with levels below this figure. The 
results of the present investigation were analyzed in this 
way, and the result showed a close similarity between the 
two groups (Chart 12).
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CHART 12.
T~comparison of the effect of-adequate and inadequate 
levels of salicylate in the blood upon the Erythrocyte 
Sedimentation Rate.
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It therefore appears that massive doses of salicylate 
do not accelerate the fall of the erythrocyte sedimentation 
rate to normal. Similar conclusions have been reached by 
many others• Wegria and Smull (1945) found that the
length of time needed for the sedimentation rate to reach 
normal differed only slightly in adequately treated and the 
control groups of »cases. They thought, however, that early 
treatment might shorten the course of the disease. This 
was not the experience of Keith and Ross (1945) whose 
patients began salicylate therapy within one or two days of 
the onset of the illness. In spite of this advantage, the 
interval that elapsed before the erythrocyte sedimentation 
rate of these cases became normal ranged from lj - 12 weeks 
on the high dosage; and 2 - 1 2  weeks in those on the low 
dosage.
Warren et al. (1946) in a study of 136 cases of 
rheumatism found that large doses of salicylate were no 
more effective than small doses in reducing the raised 
sedimentation rate* They pointed out that in a certain 
number of cases the attacks were monocyclic and that in 
such cases the erythrocyte sedimentation rate showed a
prompt return to normal* If salicylates were given to 
such individuals the erythrocyte sedimentation rate curve 
would suggest a markedly beneficial effect* In polycyclic
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infections the erythrocyte sedimentation rate fluctuates.
The administration of salicylates to these cases during 
a falling phase would lead to a false conclusion and the 
withdrawal of the drug, at the beginning of a rise, to the 
idea that the salicylate therapy had been discontinued 
prematurely. Wright (1945) found that the response of the 
sedimentation rate to both intravenous and massive oral 
dosage was disappointing and, in a large proportion of cases, 
failed to approach normal until the third to the sixth week 
of treatment.
On the other hand Manchester (1946) supported the claim 
that the erythrocyte sedimentation rate fell to normal much 
earlier in cases receiving massive dosage. Taran and 
Jacobs (1945), who worked with children, were of the same 
opinion. Reid (194&) also agreed with Coburn that a 
plasma salicylate level between 3 0 - 4 0  mgms. per cent 
caused a more rapid return of the sedimentation rate to 
normal (i.e. 10 mms. in 1 hour). He claimed that the 
average daily fall of the erythrocyte sedimentation rate 
to normal, or during the first 21 days if a normal reading 
had not been obtained in that time, varied according to the 
concentration of salicylate in the blood. The rate of 
fall was low when the blood salicylate level was reduced 
and high when the blood salicylate level was raised. The
average daily fall of adequately and inadequately treated 
cases of the present series was calculated in this way, but 
bore no relationship to the concentration of salicylate in 
the plasma. This is clearly seen in Table 4*
Name
Initial 
E .S .R.
Average blood 
salicylate level
Average
fall/day.
J.B. 100 19.0 4.3
W.S. (1) 73 25.9 3.0
R.S. 77 19.3 3.7
M*H. 74 9.3 3.0
E.D. 70 21.3 3.0
T.C. 53 19.0 2.0
P.E. 56 19.0 2.0
A.Li. 42 16.5 1.2
M.McD.(l) 134 35.5 5.5
M.McD.(2) 114 36.3 4.4
M.A. 90 36.0 3.4
E.W. 33 32.3 3.5
C.K. 70 34.9 3.0
D.McF. 65 47.4 4*4
A o>Le • 56 43.3 2.3
W.G. 55 42.4 4*3
D*C. 52 37.3 • 1.6
W.S. (2) 25 34.6 1.3
TABLE 4 .
The relationship between the initial Erythrocyte 
Sedimentation Rate and the average daily fall of 
the Sedimentation Rate when the average concen­
tration of salicylate in the blood was either 
above or below 30 mgms. %.
The cause of a high average daily fall was not the 
level of salicylate in the blood but the initial height
of the erythrocyte sedimentation rate. The exceptions 
were the cases of D.McF.and W.G. Both had been ill for 
some time before admission to hospital and it is probable 
that the sedimentation rate had begun to fall rapidly 
at the time when treatment was commenced. There was no 
support for ReidTs conclusion that the fall of the 
erythrocyte sedimentation rate to normal is accelerated 
by adequate levels of salicylate in the blood.
The use of the erythrocyte sedimentation rate as an 
index of the efficacy of massive salicylate therapy, has 
not escaped criticism. Harris (1947) and Homburger (1946) 
have both stated that the action of the salicylates upon 
the sedimentation rate is not due to a suppression of the 
rheumatic process but to a non-specific action. They 
based their conclusions upon the fact that large doses of 
salicylate tended to lower the erythrocyte sedimentation 
rate nonspecifically in such widely different diseases as 
pulmonary tuberculosis, rheumatoid arthritis and generalised 
carcinomatosis. Rapaport and Guest (1946) found a 
significant reduction of the plasma fibrinogen during 
salicylate medication in both rheumatic and non-rheumatic
subjects, and a lowering of the sedimentation rate.
Homburger (1946) estimated that the reduction of the 
fibrinogen was comparable to that caused by liver toxins.
Lichty and Hooker (1941) suggested that the 
explanation of the non-specific action of the salicylates 
on the sedimentation rate was to be found in a paper by 
Bendien, Neuberg and Snapper. This work described in 
vitro experiments which showed that a minimum concentration 
of salicylate in the plasma of 90 - 120 mgms. per cent, 
reduced the erythrocyte sedimentation rate. The obvious 
criticism of these findings is that such levels are likely 
to cause death or grave signs of salicylate poisoning in 
a human patient. However, Homburger (1945) has since 
found that if sodium salicylate remained in contact with 
the plasma for 20 hours, at room temperature and under 
sterile conditions, then therapeutic levels of salicylate 
in the plasma produced marked slowing of the sedimentation 
rate.
HomburgerTs experiment was repeated in the present 
study but his findings were not confirmed. The addition 
of sodium salicylate up to concentrations of 100 mgms. 
per cent had little effect upon the erythrocyte sedimentation 
rate if the test was performed at once. When the estimation 
was made 20 hours after the addition of salicylate, the
sedimentation rate was reduced in some but not in all cases. 
The variation in the findings is shown in Table 5. It is 
difficult, except in case 2, to find an explanation for
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these differences. This patient suffered from nephrotic 
nephritis with low serum proteins and a raised serum 
cholesterol. A high cholesterol content in the blood 
is a recognized, though uncommon cause of an accelerated 
erythrocyte sedimentation rate (Ham and Curtis, 193$)*
ACTUAL E.S. R. CORRECTED E.S>.R.
Concentration of 
Salicylate in mgms. 
per cent.
Concentration of 
Salicylate in mgms. 
per cent.
CASE 0 20 30 40 60 100 0 20 30 40 60 100
Immediate 65 62 62 mm 64 30 30 30 30I After 24 hrs. 63 64 - 56 - 10 30 22 - 14 - 10
II Immediate
61 60 60 64 30 _ 30 30 30
After 24 hrs. 67 - 63 - 63 63 30 - 30 - 30 30
III
Immediate 64 67 66 65 65 30 30 30 30 30
After 24 hrs. 60 54 - 31 16 2 22 15 - 5 4 2
IV
Immediate 63 mm 64 63 64 30 m mm 30 30 30
After 24 hrs. 64 - - 66 66 53 30 - 30 30 10
Immediate 4$ mm 46 mm 47 47 15 15 mm 12 12V After 24 hrs. 44 - 31 - 13 22 10 - 5 - 4 4
VI
Immediate 57 57 mm 60 22 mm 22 22 mm
After 24 hrs. 54 45 - 13 - 16 - 12 - 2 -
VII
Immediate 52 mm 51 53 57 55 14 mm 14 14 14 14
After 24 hrs. 33 - 60 59 66 62 5 - 14 14 20 20
VIII
Immediate 59 57 57 57 22 mm 20 20 20
After 24 hrs. 45 35 mm 22 3.3 10 mm 5 5 5
TABLE 5. The Erythrocyte Sedimentation Rates obtained 30
minutes and 20 hours after the addition of increasing
concentrations of salicylate to the plasma. "Corrected" 
readings were read from a chart (Whitby and Britton). 
This eliminated differences due to the variations in 
Packed Cell Volume in each experiment.
This whole experiment is subject to the criticism that, 
by allowing the plasma to stand for even so short a time as 
5 - 6  hours significant slowing of the erythrocyte sedi­
mentation rate will be produced (Ham and Curtis, 193$).
This slowing was not usually seen in salicylate-free plasma 
that had stood at room temperature for 20 hours. A possible 
explanation of the effect of the salicylate is contained in 
the work of Ira Morrison (1946). She suggested that blood 
fibrinogen was composed of several fractions, and whilst one 
of these was very active in causing a rapid sedimentation 
rate, the others were relatively inert. The active fraction 
was called contractinogen. It was separated out by the 
lowest concentrations of the salting out solution, and 
"gradually clotted out of blood plasma upon standing in vitro, 
in spite of the presence of such anti-coagulants as oxalates 
and citrates.ft Morrison also remarked that - "this may 
help to explain why the blood sedimentation rate becomes 
slower after blood has been allowed to stand for several 
hours." This raises the possibility that the in-vitro 
addition of varying concentrations of salicylate causes 
contractinogen to clot and so slows the erythrocyte sedi­
mentation rate. Whilst there is no doubt that such in-vitro 
experiments sometimes slow the erythrocyte sedimentation rate, 
the conditions are so artificial that one has little confidence 
that they reproduce the actions of the salicylates in the body.
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The fact that the salicylates have not been shown to 
hasten the return of the erythrocyte sedimentation rate to 
normal does not necessarily mean that the drug has no anti­
rheumatic action, and leaves untouched CoburnTs claim that 
all the cases treated with adequate doses escaped heart 
damage* But a doubt about whether the drug can suppress 
the rheumatic reaction was raised by the case of W.G.
(who, incidentally, showed a high average daily fall of his 
erythrocyte sedimentation rate). The boy was admitted to 
hospital on 24.2*43 and was found to have large nodules on 
his occiput and small ones on his knuckles and malleoli*
His heart was enlarged and loud blowing systolic and diastolic 
murmurs were heard at his apex* Large doses of acetylsalicylic 
acid were prescribed and he soon achieved and maintained levels 
of salicylate in the blood between 35 and 53 mgms. per cent.
The erythrocyte sedimentation rate fell rapidly from the 
initial reading of 55 mms. in one hour on 26.2*43 to 3 mms. 
in one hour on 7.3.43* In spite of this and his high level 
of salicylate in the blood, more than twenty small nodules 
developed on his left elbow and those on his knees and ankles 
became more numerous. Such an occurrence casts suspicion 
upon the claim that the rheumatic reaction has been suppressed, 
and emphasises the warning given by Massell (1933) that a 
normal sedimentation rate suggests but does not prove quiescence.
It is difficult to believe that the process has been 
combatted if it is accepted that the nodules afford visible 
evidence of an active rheumatic process. Murphy (1945) 
has also recorded the appearance of nodules when the level 
of salicylates was above 30 mgms. per cent. The case of 
L.B. provided an illustration that a low sedimentation rate 
does not necessarily indicate activity. She developed 
nodules at the end of her course of salicylate, and these 
persisted and became more obvious despite the fact that 
repeated estimations of the sedimentation rate never 
exceeded 11 mms. in one hour. She did not have congestive 
failure.
The view that nodules indicate activity is not 
universally accepted since some authorities believe that 
they appear during convalescence. Perry (1934) stated 
that - "as is usual the nodules developed at the end of or 
late in the attack and in nine of the cases they appeared 
when the erythrocyte sedimentation rate had fallen to 
between 10 and 20, in six the sedimentation rate was over 
20 at the time the nodules first appeared, in the remaining 
case which was not seen until the nodules had appeared the 
erythrocyte sedimentation rate was 6."
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SUMMARY.
1. Adequate concentrations of salicylate in the plasma do 
not accelerate the return of the erythrocyte sedimentation 
rate to normal.
2* Reid’s claim that the average daily fall of the 
erythrocyte sedimentation rate to normal was increased by 
adequate concentrations of salicylate in the plasma, was not 
confirmed* A high average daily rate of fall in the 
erythrocyte sedimentation rate did not seem to depend upon 
the level of salicylate in the blood but on the initial 
height of the erythrocyte sedimentation rate.
3. The Erythrocyte Sedimentation Rates, obtained 30 minutes 
and 20 hours after the addition of increasing concentrations 
of salicylate to plasma, showed that prolonged standing 
reduced the erythrocyte sedimentation rate in some but not 
all cases* Homburger’s findings were not confirmed.
4. The development of nodules, when the concentration of 
salicylate in the blood was maintained between 35 and 53 mgms. 
per cent, is described.
5. The conclusion drawn from this section of the work is 
that from investigations centred on the erythrocyte sedi­
mentation rate, there is no advantage to the rheumatic child
in administering massive doses of salicylate.
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SUMMARY AND CONCLUSIONS*
The history of salicylate in the treatment of rheumatism 
is reviewed and particular attention given to the recent claim 
of Coburn that massive salicylate therapy will prevent the 
occurrence of cardiac damage.
A study of massive therapy in a group of rheumatic 
children is reported* The following paragraphs review the 
investigations which were made and the conclusions which 
have been drawn.
1. It has been shown that in children (i) a single dose 
of salicylate and (ii) a mixture of sodium salicylate and 
an equivalent amount of sodium bicarbonate produced almost 
identical concentrations of salicylate in the blood.
Maximum levels were reached in two hours and a slow decline 
began after four hours.
2. A single dose of acetylsalicylic acid produced a lower 
concentration of salicylate in the plasma than the above, 
took four hours to reach a maximum, but the fall in the 
concentration thereafter was slow and justified the adoption 
of six hourly administration. It was shown that there was 
a gross retardation of absorption when the drug was given
in tablet form.
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3. Although with single doses of salicylate there was no 
material difference in the concentration of salicylate in 
the plasma if sodium bicarbonate was given at the same time 
yet with prolonged administration the addition of alkali 
produced a fall in the level of salicylate in the blood.
Continued intake of ammonium chloride had the opposite effect.
It was shown that these variations were associated directly 
with the pH of the urine and that the fall in blood level with
alkali was due to increased excretion of free salicylate.
This is important if a serious effort is being made to emulate 
Coburn and maintain a high blood salicylate level. Mixtures 
of one part of sodium salicylate and two parts of sodium 
bicarbonate failed to maintain adequate concentrations in 
the blood, the range being 15 to 22 mgms. per cent. Comparable 
six hourly doses of 1 to lj grains of acetylsalicylic acid per 
pound of body weight per day did produce continued high blood 
salicylate levels of between 30 and 40 mgms. per cent.
It must therefore be concluded that children require 
salicylate in doses comparable to those needed by adults to 
satisfy C o b u m ’s stipulation for the successful treatment of 
rheumatism, and that the salicylate should be given without 
alkali.
4. Investigation of the effect of prolonged administration
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of doses such as these showed that if a loading dose in 
excess of lj grains per pound body weight was given a very 
high concentration of salicylate in the blood was obtained, 
was unnecessary and in fact dangerous. Large does were 
tolerated better when the blood concentration was raised 
more slowly to an adequate level over a period of two to 
three days. This could be done by giving lj grains of 
acetylsalicylic acid per pound of body weight per day for 
two or three days and the level could then be maintained by 
1 1/4 grains per pound of body weight per day. On this 
routine a plasma level between 25 to 47 mgms.. per cent could 
be anticipated with confidence. The successful maintenance 
of such levels was shown to depend on the efficiency of the 
nursing staff and fell when the standard of nursing attention 
deteriorated.
For two reasons (i) because of the liability of the 
child to toxic upset in the initial stages of treatment, 
and (ii) because of the constant need for skilled nursing 
throughout the period of treatment it is apparent that massive 
salicylate therepy. is suitable for use only in an efficient 
hospital and quite unsuitable for treatment at home.
5. The incidence of salicylate intoxication has increased 
since the resumption of massive salicylate therapy. Vomiting, 
hyperpnoea, and listlessness were common. Vomiting was not
caused by constipation but tended to show dependence on the 
blood salicylate level. The average blood salicylate 
concentration when vomiting began was 37 mgms. per cent. 
Hyperpnoea was noticed when the level of salicylate in the 
blood was 41 mgms. per cent and the early stage of hyperpnoea 
increase in depth of respiration without increase in rate - 
was the best clinical indication that the concentration of 
salicylate in the plasma was adequate. Listlessness was 
common but difficult to assess, particularly in the first 
few days of treatment if the child has just been admitted 
to hospital and had therefore no "normal” behaviour to 
guide the observerTs conclusions. Other signs of overdosage 
an acneiform rash in one instance and epistaxis in three 
others - were too indefinite to be of clinical value in 
estimating an overdose of salicylate.
It was found that two commonly mentioned features of 
salicylate toxicity in adults - tinnitus and deafness - 
were not often noticeable in children.
6. The possible complications induced by massive salicylate 
treatment of rheumatism are further extended by the study 
of four instances of so-called rheumatic pneumonia. These 
developed when the blood salicylate was at a high level or 
a patient was unable to tolerate the drug. Though three 
made a spontaneous recovery on the discontinuation of
salicylate, the fourth was a source of considerable anxiety 
for some days andhad to be treated with intravenous fluid 
and oral digoxin before that anxiety was allayed. It is 
suggested that the occurrence of four rheumatic pneumonias 
in a small unselected series of 32 children with acute 
rheumatism is abnormal and indicates some association with 
the treatment they received - massive salicylate therapy. 
This again emphasises the unsuitability of such treatment 
for home use.
7. The sedimentation rate is generally accepted as an 
indicator, except in the presence of congestive failure, 
of the activity of a rheumatic infection. In this study 
it was found that adequate concentrations of salicylate in 
the plasma did not accelerate the return of the erythrocyte 
sedimentation rate to normal. A high average daily rate 
of fall did not seem to depend upon the level of salicylate 
in the blood but on the initial height of the erythrocyte 
sedimentation rate itself.
£. The erythrocyte sedimentation rate obtained thirty 
minutes and twenty hours after the addition of increasing 
concentrations of salicylate to the plasma in vitro, showed 
that prolonged standing reduced the rate in some but not 
all cases. This was taken as an indication that any fall
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in the erythrocyte sedimentation rate in rheumatic children 
was associated with an improvement of their pathological 
condition and not with the blood level of salicylate; in 
fact that the erythrocyte sedimentation rate and the plasma 
salicylate levels were not related to one another. This 
conclusion was confirmed by the finding of freshly developed 
nodules in children whose blood salicylate had been maintained 
at values between 35 and 50 mgms. per cent. The present 
observations on the erythrocyte sedimentation rate, and some 
supporting evidence from the literature, are disappointing 
from a therapeutic point of view and do not give any support 
for continuing the use of massive doses of salicylates.
9. The overall impression is one of disappointment. In 
no single respect has it been possible to show any major 
benefits to the rheumatic child when large doses of salicylate 
were given. On the other hand such treatment may actually 
produce deterioration in the patient!s condition by provoking 
signs of salicylate intoxication or precipitating an attack 
of rheumatic pneumonia« Further, the treatment is only 
feasible in hospital, with a high standard of nursing care, 
and unsuitable for use in the home. The greatest argument 
in favour of massive salicylate therapy, prevention of 
cardiac damage, was disproved by the development of cardiac
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lesions in some of the children while under observation 
for this study.
The treatment of juvenile rheumatism with massive 
doses of salicylate cannot be recommended.
A P P E N D I X  I .
METHOD OF DETERMINING THE PLASMA LEVEL OF SALICYLIC ACID.
Salicylate Therapy in Rheumatism.
A.F. Coburn ) Bulletin JohnsHopkin*s*Hospital 
_____________________ 73:435 (1943).___________
rTl cc of plasma is placed in a 30 cc stoppered flask.
To this add 0.5 cc 5]\j HC^ an^ 20 cc of ethylene dichloride. 
The flask is agitated on a shaking machine for at least 5 
minutes. An aliquot of 10 cc is removed in a syringe with 
a long needle, special care being taken not to contaminate 
the ethylene dichloride layer with the supernatant acid- 
water layer. The ethylene dichloride aliquot of 10 cc is 
placed in another stoppered flask to which is added 10 cc of 
distilled water and 0.5 cc of 1% ferric nitrate. The flask . 
is again agitated in a shaking machine for 5 minutes.
About 7 ccs of the supernatant purple water layer are 
removed. The colour is matched promptly in a colorimeter 
against a known standard concentration of sodium salicylate 
in plasma, which has been treated in parallel with the samples 
to be tested. The content of salicylate in plasma is 
calculated. It is convenient to use larger quantities of 
plasma if the salicyl radicle is below 100 gamma/cc. The
content of the drug in the erythrocytes is negligible.TT
The method used in the determination of the free salicylate 
in.the urine of M.McD. and WoG. (Charts 4 and 5).
Smith, Gleason, Stoll and Ogorzalek J.Pharmacology $7: 237
fT STAND ARP SOLUTIONS.
Sodium salicylate solution: 1.160 Gm of sodium sali­
cylate dissolved in water and made up to 1 litre. 1 cc of
plasma, 1 cc of water and 0.5 cc of 6 N HC1 and 30 cc of
ethylene dichloride in a 60 cc glass stoppered Pyrex bottle. 
Shake vigorously for 5 minutes in a shaking apparatus.
Transfer the mixture to a 50 cc centrifuge tube and centrifuge 
for 5 minutes at a moderate speed. Remove the supernatant 
aqueous layer by aspiration. Transfer exactly 20 ccs of 
ethylene dichloride layer to a dry 60 cc glass stoppered 
bottle, add 10 cc of water and 0o25 cc of iron reagent.
Shake for 5 minutes. Transfer at least 6 cc of supernatant 
aqueous layer to a colorimeter tube. Read in the Evelyn 
colorimeter using a filter with maximum transmission of 
540 mu. Read from the ethylene dichloride curve for plasma.
SALICYL FRACTIONS IN URINE.
a. Urine diluted 1 to 10 or 1 to 20 and the extraction 
is carried through with ethylene dichloride as for plasma 
and the values are read in the ethylene dichloride curve 
of the graph.
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b. Similar procedures used with carbon tetrachloride 
as the solvent and the results are read on the carbon 
tetrachloride curve of the graph.
c. A procedure similar to that with ethylene dichloride 
is employed but, instead of dilute acid and water, 0.5 cc 
dilute urine and 1 cc of concentrated HC1 are added and the 
mixture hydrolysed for 3 hours by immersing the lower part
of the bottles in the steam bath. After cooling 1.0 cc of 
water, 30 ccs of ethylene dichloride are added, and the 
procedure carried out at above. The readings are then made 
on the standard curve for ethylene dichloride and multiplied 
by the appropriate dilution factor. The results are calcul­
ated as below
SU = 2.00 ( EDC - CCl^)
SA = CCl^ - 0.04SU
ST = EDC (hydrolysed) + 0.33SU
where SA refers to free salicylate
SU refers to salicyluric acid
ST refers to total salicyl fractions as salicylate
EDC refers to reading on ethylene dichloride curve
CCl^ refers to reading on carbon tetrachloride curve.rT
The met hod used in cl e term i n ing the  Erytbrocvte Sedi--■ ■■    -...   T .I
mentation Rates 30 minutes and 20 hours after the 
addition of increasing concentrations of salicylates 
to the plasma. (Table 5« ~)
Homburger, F. Am. J. Med. Sci., 210: 163.
fTThe corrected sedimentation rate was determined by the 
method of Rourke and Ernstene, using as an anti-coagulant a 
dry mixture of A mgms of potassium oxalate and 6 mgms of 
ammonium oxalate in 5 ccs of blood.
For the study of the effects of salicylate, the plasma 
was separated from the cells by slow spinning and transferred 
to test tubes in amounts of 2 cc per tube; the sodium 
salicylate was then added in the form of a solution of 2 Gm 
in 100 ml of isotonic sodium chloride solution. One tube 
was left without salicylate as a control; to the others 
were added amounts to make concentrations of 20, 30, 60,
90, 120, 150, 130, 210 mgms per cent. The quantities of 
diluent were kept the same in all tubes by the additions of 
physiologic saline solution in amounts inversely proportional 
to the quantities of sodium salicylate used. Plasma thus 
prepared was kept sterile and was left standing for various 
lengths of time. In order to determine the erythrocyte 
sedimentation rate in such plasma, fresh cells were obtained 
from the s ame individual by slowly centrifuging oxalated 
blood and pipetting the cells into the prepared plasmas in
13.2,
amount,s resul01 ng m  tue original naema 00 ci'it value and. 
cells were left in contact for 30 - 120 minutes and the 
erythrocyte sedimentation rate was then determined as 
usual. All results are given in mms per minute and are 
corrected for a haematocrit of 45 per cent, according 
to the chart of Rourke and Ernstene. The use of this 
chart in the presence of salicylate is justified because 
this salt does not alter the mean corpuscular volume."
MODIFICATION.
In the present experiment the erythrocyte sedimentation 
rate was estimated by the Wintrobe method instead of by 
that of Rourke and Ernstene. The "corrected" readings for 
the Wintrobe method were obtained from a chart contained in 
"Disorders of the Blood", 4th Edition pg. 547, by Whitby 
and Britton.
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A P P E N D I X  II.
M.A.. aged 5i years, weight 15.4 Kilos. (34 pounds), was 
admitted to hospital on 27.3.48. Her illness began on
20.8.48 with frequent vomiting, but on 25.8.48 she 
developed pains in her right leg, right groin, and 
epigastrium. When she was admitted her ankle was slightly 
swollen; her apex beat was palpable in the fourth inter­
space in the nipple line and soft systolic and mid 
diastolic murmurs were heard at the apex. Treatment with 
acetylsalicylic acid was begun at once. Persistent 
vomiting throughout the course was ignored because the 
other signs of salicylate toxicity were mild and she had 
only slight hyperpnoea.
TREATMENT.
27.8.48 - 75 grains of acetylsalicylic acid
20.8.48 and 29.8.48 - 60 grains of acetylsalicylic acid/day
30.8.48 to 21.9.48 - dose varied between 30 - 50 grains of
acetylsalicylic acid/day.
Blood salicylate Date and frequency of vomiting.
in mgms. % _____________________________
29.8.48 : 41.6
31.8.48 : 32.0
3.9.48 : 34.0
6.9.48 : 47.2
9.9.48 : 24.8
13.9.43 : 31.2
16.9.48 : 32.8
20.9.48 : 40.0
28.8.48
29.8.48
30.8.48
31.8.48
1.9.48
2.9.48
3.9.48
11.9.48 : 2
9.9.43 : 2
10.9.48 : 1
13.9.48
14.9.48
15.9.48
16.9.48
17.9.48
19.9.48
20.9.48 
22.9.48
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E •S.R♦
in 1 hour
29.8.48 90
31.3.48 138
3 .9.48 118
6.9.43 105
9.9.48 70
13.9.48 42
16.9.48 18
Dates when 
hyperpnoea occurred
29.8.48
31.3.48
6.9.43
7.9.43 
10.9.43 
20*9*43
30.3.43
1.9.43
7.9.43
9.9.43
13.9.43
22.9.43
Dates when 
drowsiness occurred
31.3.43
1.9.43
2.9.43
14.9.43
C.B., aged H i  years, weight 34 Kilos (75 pounds), was 
admitted to hospital on 19.2.43. During a previous admission 
in 1946, he had suffered from rheumatic carditis and peri­
carditis and was dismissed home with aortic valvular disease. 
He remained well, though he tired easily, until 14.2.43 when 
he complained of pains in his joints. During the next three 
days he became breathless, fevered and delirious. On 
admission he had no joint pains nor nodules. His pulse was 
collapsing in character, and his apex beat was palpable 1/2 
inch outside the nipple line in the fifth interspace. The 
heart sounds were of poor quality and soft systolic and 
diastolic murmurs were heard at the apex. Two courses of 
salicylate therapy were stopped because he developed signs 
of salicylate toxicity. When he was dismissed home his 
cardiac condition was unchanged except that the quality 
of the sounds had improved.
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TREATMENT.
1. Acetylsalicylic acid 90 grains/day from 21.2.43 
to 23.2.43 when treatment was stopped.
2. Sodium salicylate grains 120
Sodium bicarbonate grains 60 each day from 6.3.43 to
11.3.43 when treatment 
was stopped.
Blood salicylate 
in mgms. %
E.S.R.
in 1 hour.
22.2.48 : 9.2 19.2.48 : 105
25.2.48 : 28.9 25.2.48 : 62
29.2.43 : 24.8 2.3.48 : 61
7.3.48 : 46.0 9.3.48 : 50
9.3.48 : 53.9 16.3.48 : 25
23.3.48 : 24
20.4.48 : 40
18.5.48 : 9
Date and frequency 
of vomiting.
10.3*43 : 1
Dates when Dates when
hyperpnoea developed drowsiness occurred.
23.2.43 11.3*43
11.3*43
J.B., aged 9i years, weight 26.6 Kilos. (534 pounds), was 
admitted to hospital on 2.11.47. Early in October he had 
complained of sore throat, sore ears, headache, fever and 
cervical adenitis for three days. On 31.10.47 his knees 
and ankles were painful and next day these joints, as well 
as his wrists, were swollen and sore. On admission his 
apex beat was palpable in the fourth interspace within the 
nipple line; a soft systolic murmur and a split second
sound were heard at the apex. The first of two courses 
of salicylates was stopped because of vomiting. On 
dismissal he had no enlargement of his heart but a loud 
systolic murmur was present at the apex.
TREATMENT.
1. Sodium salicylate grains 50 
Sodium bicarbonate grains 100
2. Sodium salicylate grains 50 
Sodium bicarbonate grains 25
each day from 2.11.47 
to 7*11*47 when treatment 
was stopped.
each day from 10.11.47 
to 2.12.47 when treatment 
was stopped.
Blood salicylate 
in mgms. %
E.S.R.
in 1 hour.
4.11*47 16.4 4.11.47 100
10.11.47 19*3 10.11.47 40
13.11.47 22.6 19.11.47 20
19*11.47 24*6 24.11.47 5
24.11.47 22.5 2.12.47 3
2.12.47 32.6 7.12.47 4.
Date and frequency 
of vomiting.
7.11.47 : 1
L.B., aged 6 4/12 years, weight 13.1 Kilos. (40 pounds), was 
admitted to hospital on 19*7*43. She had an attack of 
Scarlet Fever in February, 1943 and during March had pains 
in her legs and hands but no joint involvement. On 12.7.43 
she became fevered and complained of pains in her legs and 
hands. Five days later the joints of her hands became 
swollen and red. When she was examined on admission her
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metacarpal joints were swollen and red, her knees and 
ankles swollen and she resented any movement of her left 
elbow. A nodule was found on her right elbow. The 
apex beat was palpable in the fifth interspace one inch 
outside the nipple line. The heart sounds were rapid 
and of poor quality; a triple rhythm was heard at the 
apex. She had no pain after 21.7*43.
TREATMENT.
20.7*43
21.7*43 to 4.9.43
- Acetylsalicylic acid grains 70
- Acetylsalicylic acid grains 50 /day
Blood salicylate 
in mgms. %
E.S.R.
in 1 hour
21.7.48 23.5 16.7.43 56
23.7.48 31.5 23.7.43 105
29.7.48 15.2 4.3.43 22
4*3*43 21.6 3.9.43 11
9.3.43 34.0
19.3.43 33.4
3.9.43 32.0
Dates when 
hyperpnoea occurred.
25.7.43
A.C., aged 12 years, weight 36.5 Kilos. (SO pounds), was 
admitted to hospital on 6.1.43. In September, 1947 she 
developed a sore throat and was absent from school for the 
next three weeks. During October she became listless 
and complained of stiff legs. She was kept in bed from 
then onwards but in spite of this, her left shoulder became 
painful on 20.12.47. On admission she was extremely ill;
there was a defective respiratory murmur at the base of the 
right lung and the liver was palpable four finger-breadths 
below the costal margin. She had no nodules. The apex 
beat was felt in the fourth interspace in the nipple line. 
The heart sounds were almost inaudible; systolic and 
diastolic murmurs were heard at the apex, and the presence 
of pericardial friction was queried. Treatment with 
salicylate was begun on 3.1.43 but was stopped on 11.1.43 
because the patient developed congestive failure. The 
oedema became gross and failed to respond to treatment so 
the parents removed her from hospital against medical 
advice.
TREATMENT.
Sodium salicylate grains 120
Sodium bicarbonate grains 60 on 3.1.43
Sodium salicylate grains 75
Sodium bicarbonate grains 37i on 9*1.43
Sodium salicylate grains 60
Sodium bicarbonate grains 30 on 10.1.43
Treatment stopped 11.1.43.
Blood salicylate E.S.R. Date and frequency
in mgms. % in 1 hour. of vomiting
9.1.43 : 43.6
10.1.43 : 54.2
12.1.43 : 40.9
13.1.43 : 0.
6.1.43 : 19
10.1.43 : 17
13.1.43 : 3
23.1.43 : 5
16.2.43 : 2
29.2.43 : 3
3.3.43 : 2
9.1.43 : 3
11.1.43 : 3
12.1.43 : 2
26.1.43 : 2
27.1.43 : 2
Dates when deaf. 
ll.T.TB
Date when orthopnoeic
 ---- 1971.58 ----- - 
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D.C., aged 11 years and 10 months, weight 34*7 Kilos. (75 
pounds), was admitted to hospital on 25.6.43 with swollen 
and tender wrists, ankles and toes. She had suffered 
from frequent mild sore throats, and her joints were liable 
to become swollen and painful after any slight strain.
TREATMENT.
Acetylsalicylic acid grains 90/ day from 26.6.43 to 29.6.43
Acetylsalicylic acid grains 75/ day from 30.6.43 to 14.6.43
Acetylsalicylic acid grains 40/ day from 15.6.43 to 19.6.43
Acetylsalicylic acid grains,50/ day from 19.6.43 to 10.3.43
Blood salicylate 
in mgms. %
E.S.R.
in 1 hour.
28.6.48 28 .0 26.6.48 : 52
30.6.48 52.0 5.7.48 : 40
8.7.48 40.5 12.7.48 : 20
10.7.48 27.2 18.7.48 : 15
12.7.48 20.4 23.7.48 : 8
15.7.48 55.4 3.8.48 : 6
16.7.48
18.7.48
23.7.48 
4.8.4-8
10.8.48
49.6
36.2
44.2
50.4
48.8
19.8.48 : 5
Date when hyper- Dates when epis-
Date and frequency 
of vomiting.
9.7.43
12.7.43
14.7.43
1
1
2
pnoea occurred, taxis occurred.
9.7.43 1.7.43
3.7.43
4.7.43
Dates when 
deafness 
occurred
30.6.43
2.7.43
Dates when 
tinnitus 
occurred
27.6.43
23.6.43
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J.C., aged 7 1/4 years, weight 20.2 Kilos. (45 pounds) a 
known case of rheumatic carditis, was admitted to RHSC on 
27*2.4$ because he had developed headache, sore throat, 
and anorexia on 1$.2.4$ and painful knees and shins on 
20.2.4$* On admission he had neither joint involvement 
nor nodules but had a collapsing pulse and his apex beat 
was in the sixth interspace one inch outside the nipple 
line. Systolic and diastolic murmurs were present at the 
base of the heart. Three courses of salicylate treatment 
were given but stopped because of toxic symptoms. Signs 
of pneumonia appeared during the last course on 25*4.4$ 
and are described in the section on rheumatic pneumonia.
He was discharged home on 23.6.4$. His apex beat was in 
the sixth interspace lj inches outside the nipple line 
and systolic and diastolic murmurs were heard at the 
apex and base.
TREATMENT.
1. Sodium salicylate
Sodium bicarbonate aa. grains 10 every 4 hours from
2.3*4$ to 6.3*4$.
2. Sodium salicylate grains 10
Sodium bicarbonate grains 20 every four hours from
12.3.4$ to 26.3.4$.
3. Sodium salicylate grains 10 every four hours from
20*4*4$ to 25.4.4$.
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Blood salicylate E.S .R. Date and frequ<
in mgms. % in 1 hour. of vomiting
4.3.48 : 29.5 2.3.48 : 70 6.3.48 : 1
6.3.48 : 62.2 8.3.48 : 76 26.3.48 : 2
8.3.48 : 0 14.3.48 : 90 27.3.48 : 1
14.3.48 : 30.3 23.3.48 : 82 24.4 .4 8 : 1
16.3.48 : 29.5 30.3.48 : 70 25.4.48 : 2
19.3.48 : 15.0 7.4.48 : 16 28.4.48 : 1
25.3.48 : 23.5 13.4.48 : 12 1.5.48 : 1
25.4.48 : 17.6 20.4.48 : 50 2.5.48 : 1
27.4.48 : 64
5.5.48 : 63
11.5.48 : 65
8.6 .4 8 : 24
11.6.48 : 23
21.6.48 : 20
Dates when hyperpnoea 
 occurred._______
6.3.43
25.4.43 
26.4*43
27.4.43
Dates when drowsiness 
 occurred._______
6.3.43
13.3.43
26.3.43
25.4.43
26.if.ifB
27.4.43
T.C., aged d 3/4 years, weight 25 Kilos. (55 pounds), was 
admitted to hospital on 10.9.43 suffering from rheumatic 
pericarditis. A well marked friction rub was heard. He 
was treated with a sodium salicylate-sodium bicarbonate 
mixture and showed no signs of salicylate toxicity. On 
discharge his heart was not enlarged but soft systolic 
and mid diastolic murmurs were present at the apex.
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TREATMENT.
Sodium salicylate grains 60
Sodium bicarbonate grains 120 each day from 11.9*43 to
17.10.43 when treatment 
was stopped.
Blood salicylate E.S.R.
in mgms. f in 1 hour.
13.9.48 : 21.6 11.9.48 •• 53
16.9.48 : 18.4 16.9.48 •• 60
20.9.48 : 17.2 20.9.48 0• 33
23.9.48 : 23.2 23.9.48 • 2#
27.9.48 : 23.6 27.9.48 •• 13
1.10.48 : 10.0 1.10.48 •♦ 20
6.10.48 : 19.6 6.10.48 •• 6
12.10.48 : 20.4 12.10.48 «• 5
26.10.48 •• a
E.D., aged 9 1/4 years, weight 20 Kilos. (44 pounds), was 
admitted to hospital on 21.1.43. She developed a painful 
right shoulder on 14.1*43 and since then complained of 
fleeting pains in both shoulders, wrist, fingers, knees 
and ankles. There was no swelling nor redness. Nodules 
were found when she was examined on admission. The apex 
beat was palpable in the fourth interspace in the nipple 
line; a systolic murmur conducted into the axilla was 
heard at the apex. The first of two courses of salicylate 
was stopped because she developed persistent vomiting on
24.1.43. She was transferred to the Country Branch on
23.2.43. When she was dismissed her heart was not enlarged 
and no murmurs were heard.
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TREATMENT.
1* Sodium salicylate
Sodium bicarbonate aa. grains $0/day on 22.1,4$
Sodium salicylate
Sodium bicarbonate aa. grains 60/day on 23•1.4$
2. Sodium salicylate
Sodium bicarbonate aa. grains 60/day from 26.1.4$
to 28.1.4$
Sodium salicylate
Sodium bicarbonate aa. grains 90/day from 29*1*4$
to 4*2.4$
Acetylsalicylic acid grains $0/day on 5*2.4$
Acetylsalicylic acid grains 40 - 50/day from 6.2.4$
to 16.3*4$.
Blood salicylate in mgms. % E.S.R. in 1 hour.
23.1.48 : 29.3 9.2.48 : 33.8 23.1.48 •• 70
24.1.48 : 29.0 11.2.48 : 23.3 27.1.48 •• 22
26.1.48 : 2.6 14.2.48 : 21.3 6 .2 .4 8 •• 17
27.1.48 : 10.0 18.2.48 : 35.5 11.2.48 •• 7
30.1.48 : 18.7 27.2.48 : 0 16.2.48 ♦• 11
2.2.48 : 12.0 3.3.48 : 18.2 21.2.48 •• 13
6.2.48 : 16.4 9.3.48 : 0 23.2.48 •• 4
7.2.48 : 37.5
Patient vomited twice on 23.1.48
six times on 24*1.4$.
P.E., aged 12 3/4 years, weight 28.5 Kilos. (62j pounds), 
was admitted to hospital on 13*12.47* He had had tonsillitis 
early in November, 1947 and had not been well since that time. 
On 1.12.47 he complained of pain in his right knee and a 
few days later in elbows and ankles. When he was examined
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after admission he had no nodules. His apex beat was felt 
in the fifth interspace just outside the nipple line, and 
systolic murmurs were heard at the apex and base. He was 
treated with a sodium salicylate-sodium bicarbonate mixture 
and showed no signs of salicylate toxicity. On 12.1,4$ 
he was transferred to the Country .Branch. His heart was 
still slightly enlarged when he was dismissed home and a 
soft systolic murmur was present at the apex.
TREATMENT.
Sodium salicylate grains 75
Sodium bicarbonate grains 150 each day from 13*12.47
to 1$.12.47•
Sodium salicylate grains 90
Sodium bicarbonate grains 1$0 each day from 19*12.47
to 3*2*4$.
Blood salicylate in mgms. % E.S.R. in 1 hour.
15.12.47 14.5 13.12.47 75
22.12.47 21.6 22.12.47 35
29.12.47 34.3 29.12.47 27
6.1.4$ 25.5 6.1.4$ 40
9.1.4$ 19*0 11.1.4$ 15
13*1*4$ 15.0 27.1.4$ 16
27.1.4$ 15.0 3.2.4$ 13
3*2.4$ 9.1 24*2.4$ $
W.G., aged 12 years, weight 26.5 Kilos (5$ pounds), was 
admitted to hospital on 25*2.4$. He had suffered from 
frequent sore throats since he was eight years old. On
7.12.47 he complained of a painful right ankle but was
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able to return to school within a week* His left ankle 
became swollen and sore on 29.12.47 and within a few days 
other joints were involved. Salicylates were prescribed 
by the family doctor on 2.1.4# but fleeting pains in the 
joints persisted. On 23.2.4# he complained of palpitations 
and admission to hospital was arranged. Nodules were 
found on his occiput, knuckles and knees on admission. The 
apex beat was palpable in the sixth interspace in the nipple 
line; a loud systolic and early diastolic murmurs were 
heard at the apex and a doubtful diastolic murmur along 
the left border of the sternum. He received two courses 
of salicylate therapy in hospital; the first was therapeutic, 
the second was given in order to measure the excretion of 
free salicylate in the urine. Whilst under treatment the 
nodules became very numerous on his elbows and knees.
TREATMENT.
26.2.4# - 120 grains acetylsalicylic acid/day
1. 27.2.4# - 90 grains acetylsalicylic acid/day
2$.2.4$ - 75 grains acetylsalicylic acid/day
29*2.4$ to 11.3*4# - 60 grains acetylsalicylic acid/day
12.3.4# to 24.3*4# - 50 grains acetylsalicylic acid/day
25.3.4# - #0 grains acetylsalicylic acid/day
26.3.4# to 13.4.4# - 60 grains acetylsalicylic acid/day
2. 22.4.4# to 25*4*4# - 90 grains acetylsalicylic acid/day
26.4.4$ to 2#.4*4# - 90 grains of acetylsalicylic acid
and 160 grains of sodium bicar­
bonate per day.
29.4.4# to 5.5.4# - 90 grains acetylsalicylic acid/day
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Dates and frequency 
of vomiting.
27*2.4#
23.2.43
29.2.43 
1.3.4#
23.4.43 
26#4.43
26.4.43
2
2
1
1
1
1
1
Dates when hyperpnoea 
______ occurred.______
26.4.43
27.4.43 
30*4.43
2*5.43
3.5.43
4.5.43
5.5.43
Blood salicylate in mgms. % E.S.R. in 1 hour.
2 7.2 .4 3 41.9 24.4.43 : 40.0 26.2.43 : 55
2 9.2 .4 3 44*9 25.4.43 : 57.2 2.3.43 : 30
2 .3 .4 3 47.4 26.4 .4 3 : 33.4 7.3.43 : 3
4.3.43 35.5 27.4.43 : 22.3 14.3.43 : 7
3.3.43 36.3 23.4*43 : 24.3 6*4.43 : 5
12.3.43 53.0 29.4.43 : 40.0 25.4.43 : 5
14.3.43 43.4 30.4*43 : 47.6 3.5.43 : 4
19.3.43 22.0 3.5.43 : 51.0 9.5.43 : 5
23.3.43 10.0 4.5.43 i 42.0
6.4.43 30.7 5.5.43 : 43.7
13.4.43 13.9
Tinnitus occurred on 29.2.43.
Details of the excretion of free salicylate in the urine and 
the pH of the urine in the experiment shown in Chart f .
Date
24.4.43
25.4.43
26.4.43
Grams of free 
salicylate
0.033
0
0.10
0.003
0 .0 06
0.013
0.007
0.444
1.372
0.457
0.022
pH of Urine
5
5
5.5
5
5
5
5
6 
3 
3 
5
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Date Grams of free pH of Urine
salicylate
27.4.4^ 0.396
0.959
0.615
0.269
2$.4.4S o.isa
1 .3 4 2
0 .2 2 6
0 .4 S0 5
29.4.4s 0.215
0.103
0 .2 0 4
0.055
5 .5  
5
5
5 .5
M.He., aged about 9 years, weight 27.1 Kilos. (60 pounds), 
was admitted to hospital on 7 .S.4 S. In January, 194S she 
began to complain about joint pains and intermittent 
abdominal pain which lasted for six to eight weeks. On 
4.S.4S her joints again became painful and her right knee 
and mid phalangeal joints became swollen. She had an 
epistaxis. No nodules were found on admission to hospital. 
Her heart was enlarged and the apex beat was palpable in 
the fifth interspace a quarter of an inch outside the nipple 
line. A harsh systolic murmur and a doubtful diastolic 
murmur were heard at the apex of the heart. She was 
treated with acetylsalicylic acid and adequate levels were 
maintained without difficulty. Sweating was a prominent 
symptom.
1 2 3 .
TREATMENT.
7.3.43 to 3.3.43
9.3.43 to 3.9.43
acetylsalicylic acid 90 grains/day. 
acetylsalicylic acid 75 grains/day.
Blood salicylate 
in mgms. %
3.3.43
10.3.43
13.3.43
15.3.43
17.3.43
20.3.43
23.3.43
27.3.43
31.3.43
3.9.43
6.9.43
13.3
■13.4
40.0
44.0
41.0
55.2
40.3
40.3
44.0
43.0 
47.2
E.S.R.
in 1 hour.
10.3.43
17.3.43
20.3.43
23.3.43
31.3.43
6.9.43
14
14
20
6
25
4
Dates when hyper- 
pnoea occurred.
14.3.43
16.3.43
17.3.43
13.3.43
20.3.43
23.3.43 
27-3.43
Date when deafness 
 occurred.
12.3.43
M.H., aged 7 years, weight 20.1 Kilos. (43 pounds) was 
admitted to hospital on 26.12.47. She had growing pains 
in 1943- Towards the end of November, 1947 she developed 
tonsillitis and on 25.12.47 complained of pains in her 
feet.and left knee. Next day the right knee was also 
sore and her wrists were red and swollen. On admission 
she had no nodules and her heart was not enlarged. A 
systolic murmur was heard at the apex. She had an 
epistaxis on 29.12.47. There was no vomiting nor hyper- 
pnoea.
TREATMENT.
Sodium salicylate grains 60
Sodium bicarbonate grains 120 each day from 26.12.47
to 4.2.43.
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Blood salicylate 
in mgms. %
2.1.43 : 21.4
6.1.43 : 5.0
7.1.43 : 3.0
20.1.43 : 10.6
27.1.4& : 11.3
E.S.R.
in 1 hour.
2 7.1 2 .4 7 74
2 .1 .4s 57
6.1.4S 20
20.1.4S 10
24.2.43 7
C.K., aged 4i years, weight 15.3 Kilos. (35 pounds), was 
admitted to hospital on 13.3.43. In October, 1947 he fell 
down some stairs and after this complained of sore knees.
He was examined at a clinic and the diagnosis of primary 
tuberculous infection was made. On 23.1.43 he was sent 
to a convalescent home but his health did not improve.
On 23.2.43 he began to have repeated epistaxes and a 
systolic murmur was heard. When he was admitted to 
hospital he was very pale and his tonsils were greatly 
enlarged. His apex beat was palpable half an inch outside 
the nipple line and a loud systolic murmur was heard over 
this area. He had no nodules. On discharge from hospital 
the condition of his heart was unchanged.
TREATMENT.
Sodium salicylate grains 75
Sodium bicarbonate grains 37i on 16.3*43
Sodium salicylate grains 45
Sodium bicarbonate grains 22J each day from 17*3.43
to 25.3*43
Sodium salicylate grains 60
Sodium bicarbonate grains 30 each day from 26.3.43
to 13.4.43*
1 3 0 .
Blood salicylate 
in mgms. %
E.S.R.
in 1 hour.
Date when hyperpnoea 
occurred.
17.3.43 : 40.0 15.3.43 : 70 23.3.43
24.3.43 1 29.6 20.3.43 : 30
26.3.43 : 33.5 26.3.43 : 13
6.4.43 : 31.6 6.4.43 : 4
13.4.43 : 0
A . Le., aged 3 years and 10 months, weight 26.1 Kilos. 
(54 pounds), was admitted to hospital on 13.3.43. She 
suffered from a sore throat from 27.7.43 to 11.3.43. 
Abdominal pain began on 12.3.43 and on 15.3.43 the right 
great toe became painful. Two days later both her knees 
were swollen and sore. On admission she had no nodules; 
her knees and ankles were swollen. The apex beat was 
palpable in the fourth interspace one quarter of an inch 
outside the nipple line. A soft systolic murmur not 
conducted towards the axilla, was heard at the apex.
TREATMENT.
13.3.43 to 20.3.43
21.3.43 to 1.9.43
2.9.43 to 16.9.43
- acetylsalicylic acid 90 grains/day.
- acetylsalicylic acid 75 grains/day.
- acetylsalicylic acid 60 grains/day.
Blood salicylate in 
 mgms. %_______
19.3.43
21.3.43
23.3.43
27.3.43
31.3.43
6.9.43
10.9.43
16.9.43
23.2
52.0
43.0
40.3
53.2
43.2
35.2
34.4
E.S.R.
in 1 hour.
19.3.43
23.3.43
27.3.43
31.3.43
6.9.43
56
32
45
23
10
Dates when hyperpnoea 
______ occurred.______
21.3.43
22.3.43
23.3.43
24.3.43
25.3.43
26.3.43
27.3.43
Patient vomited on 21.3.43; was drowsy on 2.9.43
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A. Li., aged 10 years, weight 23.4 Kilos. (62^ pounds), 
was admitted to hospital on 2.1.43. His tonsils were 
removed early in December, 1947 and from then onwards he 
was not well. On 22.12.43 both his knees and ankles 
became swollen and painful. He was treated with salicylates 
but the joint pains kept on recurring. When he was 
examined on admission his right knee and ankle were swollen 
and red. His apex beat was felt in the fifth interspace 
in the nipple line. A soft systolic murmur was heard 
over this area. On discharge from hospital his heart was 
not enlarged and the sounds were pure.
TREATMENT.
2.1.43 to 3.1.43 - Sodium salicylate grains 60
Sodium bicarbonate grains 120/day.
9.1*43 to 15.1.43 - Sodium salicylate grains 90
Sodium bicarbonate grains 130/day.
16.1.43 to 2.2.43 - Sodium salicylate grains 90
Sodium bicarbonate grains 45/day.
Blood salicylate E.S.R. Date and frequency
in mgms. % in 1 hour. of vomiting.
3.1.43 13.9 3.1.48 : 42
5.1.43 7.1 8.1.48 : 22
8.1.43 14.0 12.1.48 : 17
12.1.48 19.1 27.1.48 : 18
19.1.48 28.6 24.2.43 : 3
27.1.48 15.6
2.2.48 10.9
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R« McG., aged 9 $/l2 years, weight 24.6 Kilos. (44 pounds), 
was admitted to hospital on 26*1.4$« In July 1947 he 
contracted Scarlet Fever and in the middle of September 
developed chorea. The choreiform movements persisted and 
so he was kept in bed until the date of admission to 
hospital. Up till then all cases of rheumatism had been 
treated with a sodium salicylate-sodium bicarbonate mixture 
and the concentrations of salicylate in the plasma were 
disappointing. He was selected as a suitable subject for 
an experiment to determine whether adequate levels could be 
obtained with acetylsalicylic acid, and the effect of 
sodium bicarbonate upon these levels. Treatment was stopped 
on 19*2.4$ because of vomiting.
TREATMENT.
30.1.4$ to $.2.4$ — 
9.2.4$ to 16.2.4$ -
17.2.4$ to 19.2.4$ -
60 grains acetylsalicylic acid/day. 
60 grains acetylsalicylic acid and 
60 grains sodium bicarbonate/day.
60 grains acetylsalicylic acid/day.
Blood salicylate 
in mgmSo %
E.S.R. 
in 1 hour.
31.1.48 12.0 26.1.48 7
5.2.48 34.1 3.2.48 5
9.2.48 49.3 10.2.48 5
11.2.48 37.3 11.2.48 g
16.2.48 24.2
18.2.48 34.8
Dates and frequency 
of vomiting.
1$.2.4$
19.2.4$
Dates when hyperpnoea 
 developed.______
9.2.4$
11.2.4$.
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D. McC., aged 9i years, weight 32 Kilos. (70 pounds), was 
admitted to hospital on 17.5.43. A description of his 
case (D.McC.) is given in the section on Rheumatic Pneumonia. 
He had no cardiac enlargement but had an apical systolic 
murmur on dismissal.
Blood salicylate E.S.R. Dates when hyperpnoea
in mgms. f in 1 hour • occurred.
18.5.43 •• 8 .5 17.5.48 •• 42 21.5.43
20.5.48 «• 4 1 .6 23.5.48 •• 32 23.5 .4 8
22.5.48 •• 4 2 .9 30.5.48 • 22 24.5 .4 8
25.5.48 •• 48.3 4.6.48 •• 30 2 5.5 .4 8
27.5.48 •• 54.0 13.6.48 •• 25 2 7.5 .4 8
30.5.48 •• 42.1 20.6.48 •• 20 2 8.5 .4 8
27.6.48 •• 16 3 0.5 .4 8
20.7.48 • 6 31.5.48
Dates when drowsiness Dates when deafness
o ccurred o c curred.
23.5.43 2^.5.43
30.5.43
M. McD. (1), aged 11 years, weight 29.6 Kilos. (65 pounds), 
was admitted to hospital on 13.3.43. She developed 
tonsillitis on 6.2.4# and a fortnight later complained of 
pain in her toes. This pain persisted until 6.3.43 when 
she complained of stiffness of her arms, back, neck and 
ankles. On admission to hospital she was obviously ill 
and unwilling to move her neck, shoulders or ankles. No 
nodules were present. Her apex beat was palpable in
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the fourth interspace half an inch outside the nipple line.
A systolic murmur was present at the apex and base. She
received a very large loading dose of acetylsalicylic acid
during the first day of treatment; later in the course the
effect of ammonium chloride upon the concentration of 
salicylate in the plasma was studied; and finally sodium 
bicarbonate was shown to reduce the concentration of 
salicylate in the plasma and to increase the excretion of 
free salicylate in the urine. She developed a pustular 
rash and this has been fully described in the text.
TREATMENT.
13.3.43
14.3.43 
6.4*43
16.4.43
17.4.43
19.4.43
- 150 grains of acetylsalicylic acid
5.4.43 - 50 to 60 grains acetylsalicylic acid/day
- 15.4.43 - 50 grains acetylsalicylic acid and
30 grains ammonium chloride/day.
- 60 grains acetylsalicylic acid and
120 grains sodium bicarbonate/day.
- 13.4.43 - 60 grains acetylsalicylic acid and
240 grains sodium bicarbonate/day.
- 60 grains acetylsalicylic acid/day.
Blood salicylate in mgms. % Dates when hyperpnoea occurred
14*3.43
16.3.43
19.3.43
24.3.43
26.3.43
2.4.43
5.4.43
7.4.43
6 4.3
69.5
33.3
20.3
30.3
19.6
25.3 
24.9
9*4.43
12.4.43
15.4.43
1 6.4 .4 3
17.4.43
19.4.43
20.4.43
25.3
21.3 
43.5
37.3
37.0 
4.3
20.0
22.4.43 : 26.9
E.S.R. in 1 hour
1 4.3 .4 3 134
2 0.3 .4 3 120
26.3.43 30
5.4.43 12
12,4.43 5
19.4.43 5.
14.3.43
15.3.43
26.3.43
15.4.43
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Details of the excretion of free salicylate in the urine 
and the pH of the urine in the experiment shown in Chart 4.
Date Grams of free salicylate pH of urine
15.4.48 0.020 5.5
0.022 5.5
0.002 5.5
0.005 5
Total 0.049
16.4.48 0.034 5
0.108 5.5
0.142 5
0.013 5
Total 0.297
17.4.48 0
0.022 5.5
0.32 5.5
0.265 7
Total 0.607
18.4.48 0.429 ' 5
0
0.446 8
0.273 8
Total 1.148
19.4.48 0.093 8
0.212 7.5
0.299 7.5
0.068 7
Total 0.672
20.4.48 0.098 5
0.097 6
0.061 5
0.060 5
Total 0.316
1 3 6 .
M. McD. (2), aged 11 years, weight 36.1 Kilos. (#0 pounds), 
was re-admitted to hospital on 3*10.43. She had been 
treated with a daily prophylactic dose of sulphadiazine 
for some months after discharge but had latterly neglected 
to take the drug. On admission she had acute rheumatic 
polyarthritis. Her apex beat was palpable in the fourth 
interspace in the nipple line and a soft systolic murmur 
was heard over this area. There were no nodules. On 
4.1*49 her heart was not enlarged and a soft systolic 
murmur was heard.
TREATMENT.
4*10.43
5.10.43 - 9.11.43
- 105 grains acetylsalicylic acid.
- 90 grains of acetylsalicylic acid/day.
Blood salicylate 
in mgms. %
E.S.R.
in 1 hour.
6.10.43 35.6 4.10.48 : 114
3.10.43 38.0 8.10*48 : 113
12.10.43 39.2 12.10.48 : 80
15.10.48 36.0 15.10.48 : 45
18.10.48 40.0 18.10.48 : 35
21.10.43 40.0 21.10.48 : 28
25.10.43 40.0 25.10.48 : 22
28.10.48 42.0 28.10.48 ! 18
2.11.43 21.0 2.11.48 : 12
Dates when hyperpnoea 
 occurred.______
6.10.43
3.10.43
9.10.43
13.10.43
13.10.43
21.10.43
22.10.43
Date when deafness 
occurred.
Date when drowsiness 
occurred.
6.10.43 7*10.43.
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Do McF.t aged $ 7/12 years, weight 22.2 Kilos, (49 pounds), 
was admitted to hospital on 3.3.4#. About 5.2.4$ he was 
suspected of having appendicitis but this diagnosis was 
not confirmed. On 29.2.4# he became listless, his ankles 
were swollen and his knees were stiff. He complained of 
pain when he walked. When he was examined on admission 
his apex beat was palpable in the fourth interspace within 
the nipple line, a systolic murmur was heard at the base 
and there were no nodules. He was treated with acetylsalicylic 
acid and whilst he was taking the drug developed nodules 
on his elbow and over the tendo Achilles. During the night 
of #.3*4# he developed hallucinations. He was transferred 
to the Country Branch on 22.3.4#. On discharge his heart 
was not enlarged but he had a soft apical systolic murmur.
TREATMENT
4.3.4#
5.3.4#
#.3.4#
25.3.4#
26.3.4#
- 100 grains acetylsalicylic acid
- 7*3.4# - 60 grains acetylsalicylic acid/day
- 2 4.3 .4# - 40-50 grains acetylsalicylic acid/day
$0 grains acetylsalicylic acid
- 13.4.4# - 60 grains acetylsalicylic acid/day.
Blood salicylate 
in mgms. %
E.S.R.
in 1 hour.
Date when drowsiness 
appeared.
5.3.4# 33.3 3.3.4# 65 7.3.4#
#.3.4# 49.7 #.3.4# 21
12.3.4# 61.0 16.3.4# #
16.3.4# 45.7 6 .4 .4 # 6
19.3.4# 34.2 Date when tinnitus
23.3.4# 10.0 occurred.
6.4*4# 20.0
#.3.4#.13.4.4# 11.4
H . McG», aged 7 11/12 years, weight 22.9 Kilos. (50 pounds), 
was admitted to hospital on 27•$*43* Erythema marginatum 
was noticed on his abdomen, buttocks and legs on 25.3.43.
Next days the rash was more marked and he complained of 
pains in his ankles, knees, wrists, groin and neck. His 
throat was sore. When he was examined on admission the 
rash was still present on the flexor surfaces of his arms.
His ankles, knees, wrists and elbows were swollen and tender. 
The tonsils were enlarged. The apex beat was palpable in 
the fifth interspace half an inch outside the nipple line 
and systolic murmurs were heard at the apex and base. He 
was discharged home after ten days because the family were 
emigrating to Australia.
TREATMENT.
27.3.43 - 60 grains acetylsalicylic acid
23.3.43 - 29.3.43 - 90 grains acetylsalicylic acid/day
30.3.43 - 75 grains acetylsalicylic acid
31.3.43 - 2.9.43 - 60 grains acetylsalicylic acid/day
3.9.43 - 90 grains acetylsalicylic acid
4*9.43 - 13.9.43 - 75 grains acetylsalicylic acid/day.
Blood salicylate E.S.R. Dates when hyperpnoea
in mgms. % in 1 hour.  occurred.______
29.3.43 : 24.3 29.3.43 : 120 30.3.43
31.3.43 s 34.4 31.3.43 : 119 31.3.43
3.9.43 : 23.6 3.9.43 : 113 4.9.43
7.9.43 : 23.0 7.9.43 : 97 7.9.43
10.9.43 : 32.3 10.9.43 : 33
Dates when drowsiness 
occurred.
Dates and frequency 
of vomiting.
31.#.4# 
4*9*4# 
10.9.4#
Date when deafness 
occurred.
31*#.4#
30.#.4# : 1 
2.9*4# : 2
Date when sweating 
occurred.
29.#.4#.
T.M., aged 11 years, weight 27*6 Kilos. (61 pounds), was 
admitted to hospital on 13.#*4#. He had been listless, 
pale and !off his food’ for several days before admission 
and then developed a red and swollen right ankle. This 
was at first regarded as a traumatic injury but later his 
left elbow became swollen, red and tender and he complained 
of abdominal pain. He was sent to hospital as a case of 
acute appendicitis but this diagnosis was altered to one 
of acute rheumatism. When he was examined on admission 
his apex beat was felt in the fourth interspace within the 
nipple line and a soft systolic murmur was heard at this 
area. He was treated with acetylsalicylic acid but 
treatment was stopped on 30.#.4# because of salicylate 
toxicity.
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TREATMENT.
14« #.4# 
1#.3.4#
23.#.4#
24.#.4#
2#.£.4#
29.#.4#
17.#.4#
2 2.a.4# 
27.a.4a 
3 0 .a.4a
90 grains 
75 grains 
60 grains 
75 grains 
90 grains 
75 grains
acetylsalicylic
acetylsalicylic
acetylsalicylic
acetylsalicylic
acetylsalicylic
acetylsalicylic
acid/day. 
acid/day. 
acid, 
acid/day. 
acid/day. 
acid/day.
Blood salicylate 
in mgms. %
17*#.4# 
19.#.4# 
23.#.4# 
27.#.4# 
30.3.4#
32.3 
4#.#
34.0
30.0
51.4
E.S.R.
in 1 hour.
17.#.4# 
23.#.4# 
27.#.4#
30.#.4# 
7.9.4# 
10.9.4#
95
40
45
40
15
11
Dates when hyperpnoea 
______ occurred.______
17.#.4#
20*3.4#
21.3.4#
23.#.4#
25.#.4#
26.3.4#
30.3.4#
Date when tinnitus 
 occurred_____
15.#.4#
Date when deafness 
 occurred_____
17.#.4#
Patient was very drowsy and incontinent of faeces on
30.#.4#.
P.M., aged 7 years, weight 20.4 Kilos. (45 pounds), was 
admitted to hospital on 9.2.4#. Every morning for three 
weeks in January, 1947 she suffered from pain and stiffness 
of her neck and hands. At the beginning of January, 194# 
she began to have flitting pains in her hands, arms, neck 
and knees but it was not until 2.2.4# that her right knee 
became swollen. When she was examined on admission, she 
had nodules on her elbows and hands. The heart was not 
enlarged and no murmurs were heard. She was transferred
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to the Country Branch on 23.2.4#* On dismissal her apex 
beat was palpable in the fourth interspace in the nipple 
line and no murmurs were present.
TREATMENT.
11.2.4#
12.2.4#
14.2.4#
1#.2.4#
12.3.4#
13.2.4#
17.2.4#
11.3.4#
19.3.4#
100 grains acetylsalicylic acid 
60 grains acetylsalicylic acid/day. 
75 grains acetylsalicylic acid/day. 
60 grains acetylsalicylic acid/day. 
90 grains acetylsalicylic acid/day. 
because of a misunderstanding.
Blood salicylate 
in mgms. %
12.2.4#
14.2.4#
13.2.4#
27.2.4#
2.3.4#
9.3.4#
19.3.4#
32.0
25.0
46.7
0
10.0
0
55.0
E.S. R.
in 1 hour.
11.2.4#
14.2.4#
21.2.4#
30.3.4#
41
15
16 
6
Dates and frequency 
of vomiting.
12.2.4# : 1 
13.3.4# : 1 
19.3.4# : 3 
20.3.4# : 1
Dates when hyperpnoea 
occurred.
19.3.4#.
S.M.« aged 5 years, weight 15*4 Kilos. (34 pounds), was 
admitted to hospital on 17.5.4#. In January, 194# she 
developed a 1 chill1 and had vague pains in her legs and side. 
Front that time onwards, she never felt really well. On 
30.4.4# her right knee and ankle became swollen and red. 
During the next week she sweated a great deal and on 12.5.4# 
she complained of vomiting, a heaving chest and nausea.
1 4 2 .
When she was admitted to hospital the apex beat was palpable 
half an inch outside the nipple line in the fifth inter­
space. Systolic and diastolic murmurs were heard at the
apex* She was treated with acetylsalicylic acid but
treatment had to be stopped because she became so listless 
and drowsy. On dismissal her apex beat was just outside 
the nipple line and a systolic murmur was heard at this 
area.
TREATMENT.
13.5.43
23.5.43
22.5.43 - 50 grains acetylsalicylic acid/day. 
29«5.43 - 40 grains acetylsalicylic acid/day.
Blood salicylate 
in mgms. %
20.5.43
23.5.43
25.5.43
23.0 
4 3.0
36.0
E.S.R.
in 1 hour.
13.5.43
25.5.43
31.5.43
29.6.43
66
50
20
3
Dates and frequency 
of vomiting.
23.5.43
27.5.43
Dates when hyperpnoea 
______ occurred.______
20.5.43
23.5.43
24.5.43
25.5.43
Dates when drowsiness 
______ occurred.______
23.5.43
24.5.43
25.5.43
26.5.43
27.5.43
23.5.43 
29.5.48
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M.S., aged 5 11/12 years, weight 19«5 Kilos. (43 pounds), 
was admitted to hospital on 27*2.4$. He had complained 
about stiff, sore joints in the morning for the previous 
fortnight. At night his ankles ached. When he was 
admitted he was found to have nodules on his occiput, 
scapulae, elbow, hands and the tendons of the peroneii.
The apex beat was palpable in the fourth interspace in 
the nipple line. A soft systolic murmur was heard over 
this area. He was discharged home on 7*3.4# and the 
condition of his heart was unchanged.
TREATMENT.
1.3*4# - Acetylsalicylic acid grains 100
2.3*4# - 7*3*4# - Acetylsalicylic acid grains 60/day.
E.S.R. Dates and frequency
in 1 hour. of vomiting.
2.3*4# : 35 2.3*4# : 1
5.3*4# : 1
W.S., aged 4 10/12 years, weight 15.# Kilos. (35 pounds), 
was admitted to hospital on 24*5*4#. On 14*3.4# he had 
had tonsillitis and a pain in his right leg. From then 
onwards he had not been well, had lost weight and lacked 
energy. On admission his apex beat was palpable in the 
sixth interspace one inch outside the nipple line.
Systolic and diastolic murmurs were heard at the apex and
Blood salicylate 
in mgms. %
2.3*4# : 33.7
4*3.4# : 3#*6
7.3.4# s 63.3
144-
a doubtful diastolic at the base* Towards the end of his 
first course of salicylate therapy acetylsalicylic acid 
was substituted for calcium aspirin, A week after this 
course of treatment was stopped he developed pain, tenderness 
and slight swelling of his elbows. When he was finally 
discharged home his apex beat was palpable in the sixth 
interspace half an inch outside the nipple line, A systolic 
and mid diastolic murmur was heard at the apex. No diastolic 
murmur was present at the base.
TREATMENT.
1. 25.5.43 to 3 1.5 .4 3 -
1.6.4$ to 1 6.6 .4$ -
17.6.4$ to 1 9.6 .4 3 -
2• 2 6.6 ,4$ to 27.6 .4 3 -
2$.6.43 to 20.7 .4 3 -
21.7.43 to 2 7.7 .4 3
Calcium aspirin - 43 grains/day 
Calcium aspirin - 60 grains/day 
Acetylsalicylic acid 50 grains/day.
Acetylsalicylic acid 60 grains/day 
Acetylsalicylic acid 50 grains/day 
Acetylsalicylic acid 40 grains/day.
Blood salicylate 
in mgms. %
27.5.4#
30.5.43 
4.6,4$
7.6.43
10.6.43
1 4.6 .4$
19.6.43 
2$.6.43
30.6.43
3.7.43
12.7.43
15.7.43
19.7.43
19.2,
23.6
35.0
29.3
25.0
22.3
34.3
39.3 
37.6
45.5
17.6
23.3 
4 6 .6
E.S.R.
in 1 hour.
24.5.43 
29.5.4$
4.6.4$
1 4.6.4$
25.6.4$
5.7.43
12.7.43
19.7.43
73
65
22
10
25
7
4
5
Dates and frequency 
of vomiting.
22.6.43
10.7.43
1
1
Dates when hyperpnoea 
______ occurred.______
5.6.43
19.6.43
20.6.43 
2$.6.43
29.6.43
20.7.43
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P . S ., aged £J years, weight 2£.£ Kilos. (63 pounds), was 
admitted to hospital on 27.10.47. During September, 1947 
she had tonsillitis and was treated with sulphonamides. In 
the middle of October she complained of pains in the groins 
and left knee. These persisted and she was admitted to a 
surgical ward because of an effusion in both knees and her 
ankle. On 7*11.47 she was transferred to a medical ward 
as a case of acute rheumatism. On examination the apex 
beat was felt in the fourth interspace in the nipple line.
A soft systolic murmur was heard over this area. She was 
removed from hospital before the completion of treatment 
because the family were planning to emigrate to South 
Africa.
TREATMENT.
2.11*47 - 7.11.47 - Sodium salicylate grains 60
Sodium bicarbonate grains 120 each day
£.11.47 - 12.11.47- Sodium salicylate grains 90
Sod ium bicarbonate grains l£0 each day
13.11.47 - 14.11.47- Sodium salicylate grains 90
Sodium bicarbonate grains 45 each day
Blood salicylate E.S.R.
in mgms. % in 1 hour.
£.11.47 : 19*2 £.11.47 : 40
10.11.47 : 23*6 10.11.47 : 36
12.11.47 : 14.7
15.11.47 : 24.3
146 a
R. S . t aged 9 years, weight 21.3 Kilos. (47 pounds),
was admitted to hospital on 19.10.47* He had rheumatic
fever at the age of 6 years. Between 13.10.47 and 
1$.10.47 he was listless and vague abdominal pains and 
an ache in the legs. On 19.10.47 he had an epistaxis 
and haematemesis. On admission the apex beat was palpable 
in the sixth interspace one inch outside the nipple line.
He had a collapsing pulse and a loud systolic murmur at the 
apex. He was transferred to the Country Branch on 14.11.47. 
One course was stopped because of vomiting.
TREATMENT.
1. 20.10.47 - 21.10.47 - Sodium salicylate grains 60
Sodium bicarbonate grains 120/day
2. 24*10.47 - 11.11.47 - Sodium salicylate grains 60
Sodium bicarbonate grains 120/day
Blood salicylate 
in mgms. %
E.S.R.
in 1 hour.
31.10.47 19.6 21.10.47 77
4.11.47 20.0 2S.10.47 22
7.11.47 19.# 4.11.47 11
10.11.47 27.0 7.11.47 10
12.11.47 26.5 12.11.47 g
1#.11.47 6
Date and frequency 
of vomiting.
21.10.47 : 2
A.W., aged 7 4/12 years, weight 22 Kilos. (4# pounds), was 
admitted to hospital on 14.7.43. He had felt easily tired 
for the previous three months. On 6.5.4# he complained of 
abdominal pain and vomiting and a provisional diagnosis of
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rheumatism was made though this was later revised and his 
appendix was removed on d.5.4$* In spite of the operation 
he remained a sickly child and was confined to his bed.
He complained of occasional pains in his calves and right 
wrist* On admission he was described as a small, pale, 
listless boy who looked ill. He had no nodules nor joint 
involvement. The apex beat was felt in the fifth inter­
space 1/4 inch outside the nipple line; and systolic and 
diastolic murmurs were heard at the apex. An X ray plate 
of his lungs taken at this time showed an increased heart 
shadow, lung congestion and a small amount of fluid in both 
pleurae. He developed a cough on 19.7.4$; an impaired note 
at the right base as well as rales and rhonchi on 21.7*4$; 
and congestive cardiac failure on 27.7*4$.
TREATMENT.
16.7.4$
20.7.4$
19.7.4$ - 75 grains acetylsalicylic acid/day.
19.$.4$ - 40-50 grains acetylsalicylic acid/day.
Blood salicylate E.S .R.
in mgms. % in 1 hour.
16.7.48 31.2 14.7.48 : 47
17.7.48 34.8 23.7.48 : 28
19.7.48 41.9 8.8 .4 8 : 15
21.7.48 14.8 25.8.48 : 10
23.7.48 17.2
29.7.48 16.4
8.8 .4 8 15.6
18.8.48 47.2 Date when vomiting
Dates when hyperpnoea 
______ occurred.______
17.7.4$
1$.7.4$
19.7.4$
20.7.4$
22.7.4$ orthopnoea
26.7.4$ "
2d.7 .4$  "
4.$.4$ "
occurred.
19.7.4$
143.
W ., aged 7 years, weight 22.0 Kilos. (49 pounds), was 
admitted to hospital on 2.5*43. She developed scarlet fever 
on 23.3*43 and when she arrived home on 17*4*43 she was 
noticed to be pale and listless. On 30.4*43 she complained 
of pain in the right hand and hip. Next day her right hip 
and right knee were swollen and she was unable to stand.
On admission her heart was not enlarged but a soft systolic 
murmur was heard at the apex.
TREATMENT.
3.5.43
10.5.43
13.5.43 
24*5.43
9.5*43 - 30 grains acetylsalicylic acid/day.
17*5*43 - 60 grains acetylsalicylic acid/day.
23*5*43 - 70 grains acetylsalicylic acid/day.
15*6.43 - 60 grains acetylsalicylic acid/day.
Blood salicylate 
in mgms. %
E.S.R.
in 1 hour.
7.5.4S 22.1 2.5.48 BB
10.5.4S 33.7 12.5.48 55
12.5.48 29.5 18.5.48 20
17.5.4S 21.5 26.5.48 10
20.5.48 36.4 31.5.48 7
23.5.48 50.3 22.6.48 12
26.5.48 47.6 9.7.48 B
3.6.48 39.6
15.6.48 22.3
Date and frequency 
of vomiting.
7.5*43
27*5*43
1
1
Dates when hyperpnoea 
______ occuned________ .
10.5.43
11.5*43
20.5.43 
23*5*43
24•5 * 43
25*5.43
Date when tinnitus 
 occurred.
10.5*43
149.
J. W ., aged 6 years, weight l£.0 Kilos. (40 pounds), was 
admitted to hospital on 3*1.4$. A description of her 
case (J.W.) is given in the section on Rheumatic Pneumonia. 
She developed severe salicylate poisoning and so treatment 
was stopped on 14.1*4$. Oedema was present between 17.1.4$ 
and 26.1.4$.
TREATMENT.
4.1.4$ - 9.1.4$ 
10.1.4$ - 14.1.4$
Sodium salicylate grains 60
Sodium bicarbonate grains 120 on each day.
Acetylsalicylic acid grains 50 on each day.
Blood salicylate 
in mgms. %
6.1.4$
13.1.4$
14.1.4$
15.1.4$
3$.3 
65.5 
65.0 
22.9
E • S. R.
in 1 hour.
6.1.4$
13.1.4$
27.1.4$
11.2.4$
24.2.4$
23.3.4$
13.4.4$
Dates and frequency
35 5.1.4$ 1
10 6.1.4$ 1
13 7.1.4$ 1
a $.1.4$ 1
5 9.1.4$ 1
9 10.1.4$
5 13.1.4$ 1
14.1.4$ 1
23.1.4$ 1
29.1.4$ 1
Date when hyperpnoea 
occurred.
Date when drowsiness 
occurred.
14.1.4$ 14.1.4$
1 5 0 .
R. W ., aged 6 years, weight 22.6 Kilos. (50 pounds), was 
admitted to hospital on 15.11.47• He had been subject 
to sore throats for several years. In September, 1947 
he complained of pains in his ankles and was treated with 
rest in bed and 30 grains of sodium salicylate a day. He 
developed a sore throat on 15.11.47 and next day had pains 
in his knees and left wrist. On admission his apex beat 
was palpable in the fifth interspace a quarter of an inch 
outside the nipple line. A systolic murmur was audible 
at the apex. When he was discharged home on 13.2.4$ the 
size of his heart remained unchanged but he had developed 
a systolic and diastolic murmur at the base in addition 
to the systolic murmur at the apex.
TREATMENT.
1. 17.11.47 - 19.11.47 - Sodium salicylate grains 60
Sodium bicarbonate grains 120/day
20.11.47 - 23.1.4$ - Sodium salicylate grains 60
Sodium bicarbonate grains 30/day.
2. 30.1.4$ - 1$.2.4$ - 60 grains acetylsalicylic acid/day.
Blood salicylate E.S.R. Date when epistaxis
in mgms. % in 1 hour. _____ occurred._____
IS.11.47 13.3 13.11.47 50
22.11.47 17.4 25.11.47 20
26.11.47 2$.6 6.1.4$ 6
20.1.4$ 10
31.1.48 $.0 27.1.4$ 9
2.2.48 4.0 5.2.4$ 7
5.2.48 13.2 9.2.4$ 5
9.2.48 25.0 16.2.4$ 6
11.2.48 $.0
16.2.4$ 14 0 7
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A P P E N D I X III.
CHART 1 .
The concentrations of salicylate in the plasma of a 
child after 12J grains of sodium salicylate, a sodium 
salicylate-sodium bicarbonate mixture, and acetylsalicylic 
acid*
name
Hours
after
Dose
CONCENTRATIONS OF BLOOD SALICYLATE IN KJMS. #
Sodium
Salicylate
Sod.Salicyl.
&
Sod.Bicarb.
Aspirin 
(Crushed)
Aspirin 
IUncrushed)
1 5.4 7.1 0.8
2 8.6 8.8 3.5 -
o'd . 3 6.5 8.4 5.9 -
4 5.9 6.8 7.0 -
9 4.0 5.4 4.4 -
CHART 2 .
The concentrations of salicylate in the plasma of an 
adult after 40 grains of sodium salicylate, a sodium 
salicylate-sodium bicarbonate mixture, and crushed and 
uncrushed acetylsalicylic acid.
NAME
Hours
after
Dose
CONCENTRATIONS OF BLOOD SALICYLATE IN MGMS. #
Sodium
Salicylate
Sod.Salicyl.
&
Sod.Bicarb.
Aspirin 
(Crushed)
Aspirin 
!Uncrushed)
1 11.3 13.9 1.7 1.7
2 16.2 16.2 6.5 2.6
J.C.S. 3 14.0 14.7 7.5 3.4
4 9.8 10.5 11.5 -
9 9.6 10.5 8.0 13.2
152.
CHART 3 .
The concentrations of salicylate in the plasma of 
5 patients dosed with lj grains of crushed acetylsalicylic 
acid per pound of body weight per day.
NAME
CONCENTRATIONS OF BLOOD SALICYLATE IN MGMS. #
1 hour 
after dose
2 hours 
after dose
3 hours 
after dose
*4- hours 
after dose
9 hours 1 
after dose
I. 3). h.8 11.2 12.0 12.0 6.k
II. 0*D. 0.8 3.5 5.9 7.0 k.k
III. H. 8.0 13.2 Ik.k 16.0 10.8
IV. D. 8.0 11.6 11.6 11.6 7.6
V. J.C.S. 1.7 6.3 7.5 11.3 8.0
CHART 4 .
The effect of oral doses of sodium bicarbonate upon 
the level of salicylate in the blood; upon the excretion 
of free salicylate in the urine; and upon the urinary pH.
This diagram is based upon figures that are recorded 
in Appendix 2, patient M. McD.
CHART 5.
The effect of oral doses of sodium bicarbonate upon 
the level of salicylate in the blood; upon the excretion 
of free salicylate in the urine; and upon the urinary pH.
This diagram is based upon figures that are recorded 
in Appendix 2, patient W#G.
1 5 3 .
CHART 6 .
The distribution of the levels of salicylate in the 
plasma of 17 rheumatic children treated with routine 
doses of a sodium salicylate~sodium bicarbonate mixture 
based upon their body weight.
The details of the levels of salicylate in the blood, 
the body weight and the doses of salicylate that were 
administered to 12 of the above children are recorded in 
Appendix 2 under the initials J.B.; T.C.; J.C.; P.E.;
W.G.; M.H.; A.Li,; M.McD.; P,S.; R.S.; J.W. and R.W.
The five other children were studied for very short 
periods and no information about them has yet been recorded. 
The levels of salicylate in the plasma and the dose of 
sodium salicylate per pound of body weight used in treating 
these patients were:-
Patient
Sodium Salicylate per 
pounds of body weight
Plasma salicylate 
in mgms. %
T.B. lj 2S.3
M;G; 14 4.2
J.L. 1J 26.5
20.a
R.McD. 14 14.4
H.McN. 1 22.6
CHART 7.
The distribution of the levels of salicylate in the 
plasma of 25 rheumatic children treated with routine doses 
of acetylsalicylic acid based on their body weight.
The details of the levels of salicylate in the blood, 
the body weight and the doses of acetylsalicylic are all
recorded in the case histories in Appendix 2„
154.
CHART 3.
The wide variation in the levels of blood salicylate 
produced by a sceme of dosage based on the recommendations 
of Wegria and Smull.
Curve 1   D.McF.
" 2 ....  M.S.
" 3   M.McD.
" 4 ....  P.M.
" 5 ....  W.G •
The case histories of the above patients are recorded 
in Appendix 2.
CHART 9.
The levels of salicylate in the plasma obtained by an 
initial dose of acetylsalicylic acid of li grains per pound 
(0.22 Gm. per Kilo.) of body weight per day.
Curve 1 
" 2
3
4
5
6 
7
D « C.
A.Le.
M.H.
E.W.
D.McC.
W.G.
T.M.
The case histories of the above patients are recorded 
in Appendix 2.
CHART 10.
The concentrations of salicylate in the blood of 
9 patients who received the same dose of salicylate in 
Hospital as at the Country Branch.
These patients were E.D.; P.E.; W.G.; M.H.;
C.K.; A.Li.; D.McF.; P . M . a n d  E.W. Their case 
histories are recorded in Appendix 2.
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